Neurotoxic effects on cerebellar granule cells and induction of ROS formation in human neutrophil granulocytes after exposure to polychlorinated biphenyls and penitrem A by Berntsen, Hanne Friis
    Neurotoxic effects on 
cerebellar granule cells and 
induction of ROS formation in 
human neutrophil granulocytes 
after exposure to polychlorinated 
biphenyls and penitrem A  
Hanne Friis Berntsen 
 
Master thesis in toxicology 
Department of Biology 
UNIVERSITY OF OSLO 
November 2010 
 2 
Acknowledgements 
The work for this thesis was carried out at the Department of Biochemistry, Institute of Basic 
Medical Sciences, Faculty of Medicine, University of Oslo. 
The PCB experiments were carried out as part of a bigger EU funded project, ATHON 
(Assessing the Toxicity and Hazard of Non-dioxin-like PCBs present in Food), that was 
aimed at studying the effects of non-coplanar PCBs.  
The studies on penitrem A were part of a cooperation project between the Section of 
Chemistry and Toxicology at the National Veterinary Institute and the Institute of Basic 
Medical Sciences, Faculty of Medicine, University of Oslo. 
I would like to thank my supervisor, Professor emeritus Frode Fonnum, for his dedication 
and support both during the experimental work and the last few months of writing up the 
thesis. 
I would also like to thank Inger Lise Bogen for introducing me to work at the laboratory, 
experimental planning, and for always being available for questions, as well as reading 
through my thesis. Furthermore, I would like thank my internal supervisor Professor Steinar 
Øvrebø for being available for questions, and Professor Sven Ivar Walaas for reading 
through my thesis, and for helpful discussions. I thank PhD student Angel Moldes-Anaya for 
great help with the issues related to the penitrem A part of my thesis. 
I would like to thank Kine, Marit, Bjørg and Mattis in the scientific group for their help and 
support, and Professor Anne Karine Østvold and Kirsten Grundt for their help at the earlier 
phase of the experiments. I would also to like to thank Professor Ketil Hylland for helping 
with statistics, and Kai for helping with the illustrations. 
I thank Rita Tansø and Avi Ring at the Norwegian Defence Establishment for teaching me 
how to cultivate the cerebellar granule cells, and for helpful advice when I had problems with 
the cell cultures. I would also like to thank Stine Martinsen for helping with blood samples.    
I would like to thank my boyfriend Christoffer and my family for understanding and support. 
 3 
And last but not least, I thank my dear brother Christopher for sacrificing endless hours 
helping me with everything from statistics to proofreading, despite having his final exams in 
medicine only weeks away.  
 
Hanne Friis Berntsen 
Oslo, November 2010
 4 
Contents 
 
 ACKNOWLEDGEMENTS ........................................................................................................ 2 
 SUMMARY ................................................................................................................................. 8 
 ABBREVIATIONS ................................................................................................................... 10 
1. INTRODUCTION AND BACKGROUND ............................................................................ 12 
1.1 ENVIRONMENTAL AND FOOD-BORNE TOXINS ......................................................................... 12 
1.2 POLYCHLORINATED BIPHENYLS ............................................................................................. 12 
1.3 PENITREM A .......................................................................................................................... 15 
1.4 REACTIVE OXYGEN SPECIES AND OXIDATIVE STRESS ............................................................. 17 
1.4.1 Formation of reactive oxygen species ........................................................................ 17 
1.4.2 Antioxidant systems and oxidative stress ................................................................... 20 
1.4.3 Oxidative stress in the brain ....................................................................................... 21 
1.5 CEREBELLAR GRANULE CELLS ............................................................................................... 22 
1.5.1 Cerebellar granule cells as a model ........................................................................... 22 
1.5.2 The MTT assay for detection of cell death ................................................................. 23 
1.6 HUMAN NEUTROPHIL GRANULOCYTES ................................................................................... 24 
1.6.1 ROS formation in human neutrophil granulocytes and choice of model ................... 24 
1.6.2 Detection of reactive oxygen species in vitro ............................................................. 25 
1.6.3 Lactate dehydrogenase assay ..................................................................................... 26 
1.7 CYTOPROTECTIVE AGENTS AND INHIBITORS OF ROS PRODUCTION ........................................ 26 
1.8 AIM OF STUDY ....................................................................................................................... 29 
2. MATERIALS AND METHODS ............................................................................................ 30 
 5 
2.1 CHEMICALS ............................................................................................................................ 30 
2.1.1 Chemicals for the cultivation of cerebellar granule cells and the MTT assay: .......... 30 
2.1.2 Chemicals for the isolation and experiments with human neutrophil granulocytes: .. 31 
2.1.3 Test chemicals ............................................................................................................. 31 
2.2 LABORATORY ANIMALS .......................................................................................................... 34 
2.3 CEREBELLAR GRANULE CELL EXPERIMENTS ........................................................................... 35 
2.3.1 Cultivation of cerebellar granule cells ....................................................................... 35 
2.3.2 In vitro toxin exposure of cerebellar granule cells ..................................................... 36 
2.3.3 MTT cell survival assay .............................................................................................. 39 
2.4 HUMAN NEUTROPHIL GRANULOCYTE EXPERIMENTS ............................................................... 40 
2.4.1 Isolation of human neutrophil granulocytes ............................................................... 40 
2.4.2 Measurement of reactive oxygen species after exposure to toxic substances ............. 41 
2.4.3 Detection of ROS with the DCF assay ........................................................................ 42 
2.4.4 Detection of ROS with the luminol chemiluminescence assay .................................... 43 
2.4.5 LDH assay ................................................................................................................... 43 
2.5 STATISTICAL ANALYSES ......................................................................................................... 44 
3. RESULTS .................................................................................................................................. 48 
3.1 NEUROTOXICITY STUDIES IN CEREBELLAR GRANULE CELLS ........................................................ 48 
3.1.1 General considerations ............................................................................................... 48 
3.1.2 Comparison of PCB 52 and PCB 180 ......................................................................... 48 
3.1.3 Effects of potentially neuroprotective substances on PCB 52 and PCB 180 toxicity.. 50 
3.1.4 Neurotoxicity of low and highly chlorinated PCBs ..................................................... 53 
3.1.5 Neurotoxicity of penitrem A at different concentrations ............................................. 55 
3.1.6 Penitrem A tested with potentially neuroprotective substances .................................. 56 
 6 
3.1.7 Survival after different exposure times to penitrem A and penitrem A with vitamin E60 
3.2 ROS FORMATION IN HUMAN NEUTROPHIL GRANULOCYTES ................................................... 61 
3.2.1 ROS formation after PCB exposure measured with the DCF assay........................... 61 
3.2.2 DCF assay measurements of ROS production after 
 PCB exposure in conjunction with potential ROS inhibitors .................................... 63 
3.2.3 Luminol-chemiluminescence assay measurements of 
 ROS production after exposure to PCBs ................................................................... 69 
3.2.4 Luminol assay measurements of ROS production after exposure 
 to PCBs in conjunction with ROS inhibitors ............................................................. 70 
3.2.5 Preliminary studies of penitrem A-induced ROS production ..................................... 75 
3.2.6 Measurements of penitrem A-induced ROS production using the DCF assay ........... 77 
3.2.7 Potential inhibitors and their effect on ROS production after  
penitrem A exposure, assessed with the DCF-fluorescence assay ............................. 78 
3.3 LDH ASSAY ........................................................................................................................... 81 
4. DISCUSSION ........................................................................................................................... 82 
4.1 MAIN RESULTS ...................................................................................................................... 82 
4.2 CEREBELLAR GRANULE CELLS ............................................................................................... 82 
4.2.1 Cerebellar granule cells as a model ........................................................................... 82 
4.2.2 Toxicity studies of low and highly chlorinated PCBs ................................................. 83 
4.2.3 Potential mechanisms of PCB neurotoxicity .............................................................. 85 
4.2.4 Penitrem A neurotoxicity ............................................................................................ 88 
4.2.5 Possible mechanisms of penitrem A neurotoxicity ..................................................... 88 
4.2.6 Neurotoxicity of penitrem A at different times of exposure ........................................ 91 
4.3 HUMAN NEUTROPHIL GRANULOCYTES ................................................................................... 92 
4.3.1 Human neutrophil granulocytes as a model............................................................... 92 
 7 
4.3.2 ROS production in human neutrophil granulocytes after PCB exposure ................... 92 
4.3.3 Assessment of pathways involved in ROS production after PCB exposure ................. 94 
4.3.4 ROS production in human neutrophil granulocytes after penitrem A exposure ......... 97 
4.3.5 Mechanisms of ROS-induction after penitrem A exposure ......................................... 98 
5. CONCLUSIONS AND FUTURE PERSPECTIVES ............................................................. 99 
6. REFERENCES ....................................................................................................................... 101 
7. APPENDIX ............................................................................................................................. 109 
7.1 SOLUTIONS FOR CEREBELLAR GRANULE CELL EXPERIMENTS ................................................ 109 
7.1.1 Solutions for the cultivation of cerebellar granule cells ........................................... 109 
7.1.2 Solutions for exposure of cells to toxic substances and MTT cell survival assay ..... 110 
7.2 SOLUTIONS FOR HUMAN NEUTROPHIL GRANULOCYTE EXPERIMENTS .................................... 110 
7.2.1 Solutions for human neutrophil granulocyte experiments ........................................ 110 
 
 8 
Summary 
Polychlorinated biphenyls (PCBs) are persistant organic pollutants that bioaccumulate and 
biomagnify through the food chain. Exposure to ortho-chlorinated PCBs has been associated 
with effects on the nervous and immune systems. Penitrem A is a mycotoxin found to cause 
neurological symptoms in dogs after ingestion of mouldy food. There have also been cases of 
suspected penitrem A intoxication in humans. 
The aim of this study was to investigate differences in neurotoxicity in cerebellar granule 
cells between low and highly chlorinated ortho-substituted PCBs in vitro, and mechanisms 
underlying their toxicity. The neurotoxic potential of penitrem A was also investigated. 
Furthermore, the ability of different PCB congeners and of penitrem A to induce ROS 
production was investigated in human neutrophil granulocytes in vitro. 
Cerebellar granule cells were exposed to low and highly chlorinated PCBs, as well as to 
penitrem A. Effects of potentially neuroprotective substances was also assessed after 
exposure to the toxic substances. The MTT assay was used to assess cell survival. 
Human neutrophil granulocytes were also exposed to low and highly chlorinated PCBs and 
penitrem A. ROS production after exposure was assessed with the DCF and luminol 
chemiluminescence assays. Effects of inhibitors of ROS production was assessed to identify 
potential pathways involved in the ROS production. 
In this study, the higher chlorinated PCBs were more toxic to cerebellar granule cells in vitro 
than lower chlorinated congeners. Cytoprotective effects were found for the substances 
vitamin E and MK-801.  This may indicate involvement of ROS production and NMDA 
receptors in PCB neurotoxicity. The lower chlorinated PCBs induced more ROS production 
in human neutrophil granulocytes than the higher chlorinated congeners. Co-incubation with 
the substances U0126, BAPTA-AM, vitamin E, SP600125, SB203580, FK-506 and CsA 
significantly reduced ROS levels. 
The mycotoxin penitrem A caused more cell death in cerebellar granule cells with increasing 
concentration and exposure time, and increasing concentrations also induced a dose 
dependent increase in ROS production in human neutrophil granulocytes. Co-incubation 
with GABA, phenobarbital, diazepam, vitamin E, BAPTA-AM, SP600125, FK-506 and 
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cyclosporine A all reduced granule cell death. This may indicate that the GABA receptor, 
ROS production, disruption of calcium homeostasis and activation of the pro-apoptotic JNK 
pathway are involved in penitrem A neurotoxicity. 
U0126, SP600125, SB203580, FK-506, cyclosporine A, vitamin E and BAPTA-AM all 
reduced ROS production in granulocytes after penitrem A exposure. This may point to an 
involvement of the MEK 1/2, MEK 5, p38 and JNK pathways in the mechanism of penitrem 
A-induced ROS production. 
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1. Introduction and background 
1.1 Environmental and food-borne toxins 
Several toxic substances that are present in food have the potential to affect the central 
nervous system in man after ingestion. Among these are the polychlorinated biphenyls 
(PCBs), which are environmental toxicants that have been found to bioaccumulate and 
biomagnify through the food chain. Humans may be exposed through foodstuffs such as fatty 
fish, shellfish, meat, liver, eggs and dairy products (La Rocca and Mantovani, 2006). 
PCBs have been associated with hyperactivity and impaired cognitive functions in children 
after exposure via mother’s milk, and decreased motor activity in exposed adults (Mariussen 
and Fonnum, 2006). Immunotoxic effects have also been reported, including altered 
gammaglobuline levels in human blood after PCB intoxication (Nakanishi et al., 1985), 
altered T- and NK cell function (Safe, 1994) as well as effects on neutrophil granulocytes 
(Ganey et al., 1993; Voie et al., 1998). Thus, it is of interest to elucidate mechanisms of PCB 
toxicity. For this thesis, in vitro models using cerebellar granule cells and human neutrophil 
granulocytes were chosen for studies of cell death and production of reactive oxygen species 
(ROS), respectively. 
During the work on the thesis, the cell models used were found to be suitable to study 
neurotoxic effects of another toxic substance found in food, which has also been associated 
with altered neurological function. The mycotoxin penitrem A has been shown to cause 
tremor, ataxia and convulsions in dogs (Moldes-Anaya et al., 2010), and there have also been 
reports of suspected penitrem A intoxications in man causing neurological symptoms (Cole 
et al., 1983; Lewis et al. 2005). 
1.2 Polychlorinated biphenyls 
Polychlorinated biphenyls (PCBs) are examples of synthetic persistent organic pollutants that 
are found widespread in nature (Fonnum et al., 2006) and have been associated with a range 
of adverse health effects including effects on the nervous system (Seegal et al., 1996) and the 
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immune system (Nakanishi et al., 1985; Arkoosh et al., 1994), as well as reproductive 
abnormalities, fetal toxicity, carcinogenicity and interference with the endocrine system 
(Safe, 1994; Fischer et al., 1998). The production of PCBs was banned in the late 1970s 
(Dreiem et al., 2009). Until this they were used in the industry as cutting oils, flame 
retardants, in transformers and capacitors, as well as for many other purposes (Safe, 1994). 
However, due to their persistence and ability to bioaccumulate and biomagnify through the 
food chain, humans are still exposed to PCBs mainly through consumption of contaminated 
food (Dreiem et al., 2009).  
PCBs are small molecules that consist of two phenyl rings connected by a carbon-carbon 
bond, with chlorine substitutions at one or more of the ten available carbons in the molecule 
(Wright and Welbourne, 2002).  
 
Figure 1-1. General molecular structure of the polychlorinated biphenyls. PCBs may be chlorinated in 
all positions except 1 and 1’, and are named according to the number and position of the chlorine 
substitutions. Adapted from Wright and Welbourn (2002). 
There are 209 possible congeners of PCBs that differ in the number and placement of their 
chlorine substitutions (Seegal et al., 1996). The PCBs are lipid soluble, and in general their 
lipid solubility and size of the molecule increases with the degree of chlorination and 
congener number (Wright and Welbourne, 2002). PCBs were combined in commercial 
mixtures and marketed according to the chlorine content of the mixture. For example, the 
brand name Aroclor 1242 meant that the product contained 42 % chlorine by weight (Safe, 
1994). 
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The PCBs are generally divided into three groups according to their structure. The first group 
comprises the coplanar, dioxin-like PCBs that have chlorine substitution only in the para and 
meta positions of the molecule and no substitutions in the ortho positions. The second group 
includes the mono-ortho-chlorinated PCBs, which may attain a coplanar configuration, and 
the third group the PCBs that have two or more ortho-substitutions. The latter are always 
non-coplanar (Mariussen and Fonnum, 2006). 
The first two groups have been found to have dioxin-like properties, binding to the aryl 
hydrocarbon (Ah) receptor and inducing CYP1A1 enzymes, and are associated with 
carcinogenicity (Safe, 1994). The third group has low affinity for the Ah receptor, but has 
been associated with effects on the nervous system (Seegal et al., 1996). Also the non-ortho-
substituted coplanar PCBs have been associated with effects on the nervous system, but they 
are thought to be less potent in this respect than the ortho-substituted (Mariussen and 
Fonnum, 2006). Exposure to PCBs during development and nursing may predispose to 
hyperactivity disorders, as well as impairment of learning and memory (Mariussen and 
Fonnum, 2006). Non-coplanar PCBs have also shown to cause activation of neutrophil 
granulocytes. This has not been observed for the coplanar PCBs (Fischer et al., 1998; Voie et 
al., 2000). 
Approximately 135 of the 209 PCB congeners have been found in environmental samples 
(Seegal et al., 1996). PCBs that are present in the environment are slowly biotransformed, 
and coplanar forms may be converted to non-coplanar forms. Eventually, a higher proportion 
of non-coplanar congeners is found in the environment than what was originally found in the 
commercial mixtures. The PCBs detected in human blood and tissues, as well as in wildlife 
and fish, are mainly non-coplanar congeners (Fischer et al., 1998).  
The PCBs used in this thesis are presented in figure 1.2. 
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2,4,4'-trichlorobiphenyl (PCB 28)            2,2',5,5'-tetrachlorobiphenyl (PCB 52) 
 
2,2',4,5,5'-pentachlorobiphenyl (PCB 101)           2,3,3',4',6-pentachlorobiphenyl (PCB 110) 
 
2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153)           2,2',3,4,4',5,5'-heptachlorobiphenyl (PCB 180) 
Figure 1-2. Molecular structures of the ortho-chlorinated PCBs 28, 52, 101, 110, 153 and 180. 
1.3 Penitrem A 
Substances produced by certain moulds growing on food are capable of producing 
intoxication in man and animals (Newberne, 1974). These so-called mycotoxins are 
secondary metabolites that are not necessary for the survival of the moulds. They may be 
produced in situations where they give the organism a competitive advantage. Certain 
mycotoxins, including penitrem A, are capable of inducing neurological disorders in 
vertebrates including convulsions, tremor and ataxia (Moldes-Anaya et al., 2009).  
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The structure and chemical characteristics of the different mycotoxins exhibit a great deal of 
variation. Most of the tremorogens that have been found to be involved in 
neuromycotoxicosis contain an indole alkaloid unit in their structure (Moldes-Anaya et al., 
2009). Penitrem A is a potent indole diterpenoid (Moldes-Anaya et al., 2010) belonging to a 
group of mould contaminants known as tremorogenic mycotoxins (Sobotka et al., 1978). It is 
produced mainly by the fungus Penicillium crustosum, and has been associated with 
neurological symptoms and even death in animals (Moldes-Anaya et al., 2010). Neurological 
symptoms in man, including tremor, have been reported on a few occasions after the 
ingestion of Penicillium crustosum (Cole et al., 1983; Lewis et al., 2005). Further 
investigation on the effect of tremorogenic moulds on human health is required due to the 
probable underreporting of such cases in man (Moldes-Anaya et al., 2010). 
 
Figure 1-3. Molecular structure of penitrem A. After Moldes-Anaya (2010), with permission. 
Penitrem A is able to cross the blood brain barrier (Moldes-Anaya et al., 2009; Eriksen et al., 
2010), and signs in intoxicated animals appear within 30 minutes to 3 hours after exposure. 
The mechanisms responsible for the neurological symptoms are not well understood, but 
may include activation of the glutamatergic system, interference with the GABAergic 
inhibitory system as well as blockage of high conductance calcium activated potassium 
channels (BK channels) in the presynaptic neuronal membrane. (Moldes-Anaya et al., 2010). 
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1.4 Reactive oxygen species and oxidative stress 
1.4.1 Formation of reactive oxygen species 
Free radicals have been defined by Halliwell and Gutteridge (2007) as “any species capable 
of independent existence that contains one or more unpaired electrons”. The fact that they 
have unpaired electrons makes some of them highly reactive. Many of the molecules defined 
as reactive oxygen species (ROS) are free radicals, of which some examples are hydroxyl 
radicals (
•
OH), superoxide radicals (O2
•-
) and nitric oxide (NO
•
). The term, however, also 
includes derivatives of oxygen that are not radicals, such as hydrogen peroxide (H2O2), 
hypochlorous acid (HOCl) and ozone (O3). 
Reactive species that contain chlorine, bromine, sulphur and nitrogen in addition to oxygen 
are included in the term as well, although they could also be described as reactive chlorine, 
bromine, sulphur and nitrogen species, respectively. Some examples are peroxynitrite 
(ONOO
-
), and the above mentioned NO
•
 and HOCl. The reactivity of the different ROS, and 
the molecules with which they react, vary between the different species. ROS such as O2
•-
, 
NO
• 
and H2O2   react fast and very selectively with certain biological molecules. 
•
OH, 
however, is not so specific and reacts rapidly with most molecules (Halliwell and Gutteridge, 
2007). 
ROS are products of the normal cell metabolism in the presence of oxygen. Most are 
produced through oxidative metabolism in mitocondria, enzymatic mixed-function oxidation 
reactions and autooxidation of small molecules (Simonian and Coyle, 1996). An overview of 
ROS production in the cell is illustrated in figure 1.4.  
O2
•- 
is formed by reduction of molecular oxygen, and may be created inside the cell when 
high energy electrons leak from the electron transport chain in the mitochondria. It may also 
be formed by the action of several enzymes located in the cytosol, plasma membrane or 
nuclear membrane. Such enzymes include phospholipase A2 (PLA2), xantine oxidase and 
NADPH oxidase in phagocytes (Simonian and Coyle, 1996; Halliwell and Gutteridge, 2007). 
O2
•- 
generation is thought to happen within all aerobic cells. This ROS
 
is not thought to be as 
reactive as e.g. 
•
OH, and does not react with most biological molecules in aqueous fluids 
(Halliwell and Gutteridge, 2007). O2
•-
 may be converted to ONOO
-
 by reacting with nitric 
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oxide (NO
•
) or to H2O2 by the action of superoxide dismutase (SOD) (Simonian and Coyle, 
1996).  
NO
•
 is a stable free radical, that has several functions under physiological conditions both in 
the nervous system and the vascular system (in these cases often simply referred to as NO). It 
acts as a neurotransmitter, and is involved in memory functions, blood pressure regulation 
and killing of foreign organisms (Halliwell and Gutteridge, 2007).  It has, however, also been 
suggested as an important cause of nerve cell death during pathological conditions, possibly 
through the generation of ONOO
-
 (Simonian and Coyle, 1996).  
ONOO
- 
is a highly reactive molecule, but is more stable than 
•
OH and O2
•-
, allowing it to 
diffuse over greater distances. It
 
may react with and produce alterations in lipids, proteins 
and DNA. ONOO
-
 may be converted into 
•
OH, which may also attack the same molecules 
(Simonian and Coyle, 1996), and NO2
•
. The latter is of intermediate reactivity (Halliwell and 
Gutteridge, 2007). 
•
OH is the most potent of the ROS, and has a very short half-life. As mentioned above, it 
may react with most biological molecules, thus initiating free-radical chain reactions 
(Betteridge, 2000). In addition to production from ONOO
-
, 
•
OH may be produced from H2O2 
via the Fenton reaction displayed below. Other intermediate ROS may be generated in the 
process (Halliwell and Gutteridge, 2007). 
Fenton reaction: H2O2 + Fe
2+
 → intermediate ROS →  Fe3+ + OH- + OH• 
H2O2 itself is not so reactive, and is continuously produced in most tissues of the body 
(Halliwell and Gutteridge, 2007). It is produced along the electron transport chain through 
autooxidation of small molecules. As mentioned, it may also be produced through 
conversion of O2
•-
 catalysed by SOD (Simonian and Coyle, 1996). H2O2 is quite water 
soluble, and may diffuse within and between cells. It is capable of entering cells through 
membrane water channels (aquaporins), and probably also by other mechanisms. Even 
though it has a low reactivity, H2O2 can be cytotoxic at high concentrations, and may thus 
have antibacterial properties. It does not damage lipids, DNA or proteins in its own right, but 
crosses cell membranes where. Intracellularly, it may be converted to OH
•
 and HOCl 
(Halliwell and Gutteridge, 2007). 
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HOCl is produced from H2O2 and Cl
-
 through the action of myeloperoxidase. The 
myeloperoxidase enzymes are found in phagocytic cells such as the neutrophil granulocyte. 
They are located in granules in the cytosol that fuse with phagocytic vacuoles, where HOCl 
is created that may have cytotoxic effects on engulfed bacteria.  
 
Figure 1-4. An overview of ROS production mechanisms and antioxidant mechanisms in the cell. 
H2O2 may be formed from O2
•- 
through the action of superoxide dismutase (SOD). H2O2 is converted 
to water by glutathione peroxidase. GSH and GSSG represent the reduced and oxidised forms of 
glutathione, respectively. Furthermore, H2O2 is converted to HOCl by myeloperoxidase (MPO), and to 
water and molecular oxygen by catalase. In the presence of iron, H2O2 may also be converted to 
•
OH-
radicals through the Fenton reaction. O2
•- 
may react with NO
•
 to form peroxynitrite (ONOO
-
), which 
may further be converted to NO2
•
 and 
•
OH. Adapted from Rykken (2004). 
H2O2 and O2
•-
 are produced in the body both physiologically and as unavoidable by-products. 
They may be created where molecules in the body react with oxygen, or, as mentioned 
above, when electrons escape from the mitochondrial electron transport chain. Physiological 
ROS formation takes places in phagocytes. H2O2 and O2
•-
 are involved in phagocyte 
functions, including killing of invading pathogens such as bacteria and fungi and inactivation 
of viruses. However, inappropriate activation of phagocytes may also produce deleterious 
effects, as observed in chronic inflammatory diseases (Halliwell and Gutteridge, 1997). 
 20 
1.4.2 Antioxidant systems and oxidative stress 
The formation of ROS in the body is counterbalanced by antioxidant defence systems. These 
systems include both intrinsic body functions, and antioxidants supplied through food. Inside 
the cell, SOD converting O2
•-
 to H2O2 acts in parallel with enzymes that remove H2O2, such 
as catalase and glutathione peroxidase (GSH-Px), and convert the ROS to water (Halliwell, 
1997). Other examples of antioxidant defence systems include iron binding and storage 
proteins such as transferrin and ferretin, that prevent the creation of damaging 
•
OH radicals 
by binding iron (Halliwell, 1997). Furthermore, ceruloplasmin binds copper ions and 
oxidises iron without the creation of ROS, and also prevents lipid peroxidation. Vitamin E 
and reduced glutation (GSH) are preferentially oxidised by ROS, thus scavenging ROS that 
might otherwise cause damage to important biomolecules (Simonian and Coyle, 1996; 
Halliwell and Gutteridge, 2007).  
If the balance between ROS production and the cell defence mechanisms is upset, oxidative 
stress may occur. This imbalance may result in cellular dysfunction or even cell death, 
because of damage to molecules such as lipids, proteins and DNA (Simonian and Coyle, 
1996). ROS have been suggested as an important factor contributing to cell damage during 
inflammation, ischemia, cancer and aging (Myhre et al., 2003), and are possibly also 
involved in neurodegenerative diseases of the brain (Beal, 1995).  
Several kinds of stimuli, including environmental contaminants, may induce high levels of 
ROS formation in the cell, causing them to enter a state of oxidative stress (Finkel and 
Holbrook, 2000; Myhre et al., 2003). Whether the cell survives or not depends on its ability 
to withstand stress and repair damaged molecules. If the damage is large enough, the cell will 
enter apoptosis or necrosis (Simonian and Coyle, 1996).  
Increased levels of ROS in the cell may potentially activate specific intracellular pathways 
(Finkel and Holbrook, 2000). Some of the main stress signalling pathways/mediators 
activated by oxidant injury are the extracellular signal-regulated kinase (ERK) pathway, the 
c-Jun amino-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK) 
signalling cascades, the phosphoinositide 3-kinase (PI(3)K/AKT) pathway, the nuclear factor 
(NF)-κB signalling system, as well as the p53 and the heat shock response pathways. p53, 
JNK and p38 activation is most often associated with apoptosis after oxidant injury, whereas 
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the rest act pro-survival. These pathways are not uniquely involved in oxidative stress, but 
also in other stress responses, as well as growth and metabolism regulation (Finkel and 
Holbrook, 2000). 
1.4.3 Oxidative stress in the brain  
Glutamate is the most prominent excitatory neurotransmitter in the brain. Excitotoxicity 
refers to the death of neurones due to excessive activation of excitatory amino acid receptors 
(Beal, 1995; Simonian and Coyle, 1996). This it is an important factor in neuronal 
degeneration after acute conditions such as hypoxia, ischemia and trauma (Simonian and 
Coyle, 1996).  
Intracellular calcium homeostasis is crucial for the maintenance of normal cell function. 
Disruption of the homeostasis and increased intracellular levels of free calcium may 
potentially lead to the production of ROS. Increased Ca
2+
-levels may also affect 
neurotransmitter release and activation of phosphokinases, phosphatases and phospholipases. 
Furthermore, it may affect protease activities, apoptotic processes, and the activity of nitric 
oxide synthase (NOS) (Mariussen and Fonnum, 2006).  
The brain is a region of the body that is particularly vulnerable to oxidative stress. Among 
the reasons for this are low levels of the enzymes catalase, SOD and GSH-Px. High contents 
of iron in certain brain areas may also catalyze the formation of 
•
OH. The nerve cell 
membranes also have a high content of polyunsaturated fatty acids that are particularly 
vulnerable to ROS-induced damage, such as lipid peroxidation and impairment of membrane 
function (Mariussen et al., 2002).  
Formation of ROS in cerebellar granule neurons has been thought mainly to be the result of 
release from mitochondria and activation of neuron specific enzymes (Coyoy et al., 2008). 
Increases in intracellular free calcium may result in the activation of NOS, causing the 
formation of NO
•
, as well as the activation of protein kinase C (PKC) and phospholipase A2 
(PLA2), leading to the formation of O2
•-
. In addition, calcium may cause the opening of 
mitochondrial transition pores with subsequent increases in the production of O2
•-
 (Fonnum 
et al., 2006). 
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Coyoy et al. (2008) found that cerebellar granule cells contain an NADPH oxidase system 
homologous to the one present in phagocytic cells, and that NADPH inhibitors caused 
decreased O2
•-
 production. This suggested a role for the NADPH oxidase in ROS production 
also in cerebellar granule cells. They also postulated a role of PKC in its activation (Coyoy et 
al., 2008).  
1.5 Cerebellar granule cells 
1.5.1 Cerebellar granule cells as a model 
The cerebellum is a part of the brain that is involved in the control of movements. Granule 
cells are the most abundant neurons in the cerebellum, and are suited as a model for in vitro 
studies of effect of toxic substances on nerve cells (Gallo et al., 1982). Together with the 
Purkinje cells they are the most important targets in the cerebellum for toxic substances.  
During brain development, different cell types develop at different times. The cerebellar 
granule cells develop post-natally, and are formed on day 7-15 with a peak at days 10-11, as 
compared to the Purkinje cells, which are formed in utero (Fonnum and Lock, 2000). The 
fact that the cells develop post-natally makes them relatively easy to isolate, and cultures 
may be produced from rat or mouse pups from day 7 or 8 after birth. Furthermore, it is 
possible to obtain a quite pure culture of these neuronal cells by adding cytosine 
arabinofuranoside (ARA-C), which prevents the replication of glial cells (Gallo et al., 1982). 
The cerebellar granule cells are also well suited for in vitro studies of cellular and molecular 
mechanisms for survival and cell death (Reistad et al., 2006). The benefit of using primary 
cultures of nerve cells instead of cell lines, is the fact that intracellular pathways are kept 
intact. The cells do not undergo transformations that may potentially alter cell activities, as 
one may see in cell lines (Aam, 2007). 
Cerebellar granule cells have glutamatergic receptors where excitotoxicity may be induced, 
involving increases in free intracellular calcium and ROS formation (Fonnum and Lock, 
2000). As PCBs have been shown to act via the NMDA receptor and to produce increases in 
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ROS in cerebellar granule cells, these cells are suited for studies on PCB neurotoxicity and 
PCB-induced ROS formation (Mariussen and Fonnum, 2006). 
There have been no published studies on the effects of penitrem A in cerebellar granule cells. 
However, post mortem examination of dogs that have been intoxicated with penitrem A 
reveals extensive damage to the cerebellum (Moldes-Anaya, 2010), but not to any other parts 
of the brain. This selective damage to the cerebellum was also found in in vivo experiments 
by Breton et al. (1998) and Cavanagh et al. (1998). Breton et al. (1998) found an extensive 
loss of Purkinje cells that was hypothesised to have resulted from excitotoxicity due to the 
activation of glutamatergic receptors. Cavanagh et al. (1998) also found discrete foci of 
necrosis in the granular cell layer in addition to large losses of Purkinje cells. Due to the 
selective toxicity of penitrem A to the cerebellum, it was considered that it might yield 
interesting results to study exposure of cerebellar granule cells to penitrem A. 
1.5.2 The MTT assay for detection of cell death  
Several different methods are available for the measuring survival in cells during cytotoxicity 
experiments. Certain methods are based on counting cells after inclusion or exclusion of a 
dye (e.g. the trypan blue exclusion assay) or measurement of released 
51
Cr-labeled protein 
after cell lysis (Mosmann, 1983). 
The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay is a method 
of measuring the activity of living cells via mitochondrial dehydrogenases (Sigma Aldrich, 
n.d.). It is based on the cleavage of the yellow tetrazolium salt MTT into the blue coloured 
product formazan by the mitochondrial enzyme succinate-dehydrogenase. The conversion 
happens only in living cells, and the amount of formazan produced is proportional to the 
number of living cells present (Denizot and Lang, 1986). The resulting formazan may be 
dissolved in an appropriate solvent, and values measured spectrophotometrically. A decrease 
in the number of living cells will cause a change in the amount of formezan produced, and 
indicate the degree of cytotoxicity caused by the toxicant (Sigma Aldrich, n.d.).  
The method was chosen in preference to the trypan blue assay, which has traditionally been 
used in PCB toxicity studies (Dreiem et al., 2009), because trypan blue is classified as a 
possible human carcinogen (International Agency for Research on Cancer, 1998). 
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Furthermore, the MTT assay is rapid to perform, and is not based on subjective evaluation of 
cell numbers, as the trypan blue assay is. 
1.6 Human neutrophil granulocytes 
1.6.1 ROS formation in human neutrophil granulocytes and choice 
of model 
Human neutrophil granulocytes are an important part of the innate immune system protecting 
us from invading pathogens, as well as an important factor in acute inflammatory reactions. 
During an immune response, neutrophil granulocytes form ROS aimed at killing 
microorganisms (Fonnum et al., 2006). When neutrophil granulocytes ingest pathogens via 
phagocytosis they increase their consumption of molecular oxygen. This is called the 
respiratory burst. An activated form of the enzyme NADPH oxidase is assembled in the part 
of the plasma membrane that will form the phagocytic vacuole (Halliwell and Gutteridge, 
2007).  
O2
•-
 and H2O2 are produced from molecular oxygen through donation of electrons from the 
NADPH oxidase, and may either be released extracellularly or into the phagocytic vacuole 
where they may kill certain pathogens (Dahlgren and Karlsson, 1999). Further conversion 
into HOCl, ONOO
-
 and possibly 
•
OH and O3 promotes further pathogen killing. MPO may 
also be released extracellularly where it causes formation of HOCl (Halliwell and Gutteridge, 
2007). Although the respiratory burst is important for the defence against pathogens, it may 
also cause deleterious effects such as tissue destruction during chronic inflammatory 
reactions (Dahlgren and Karlsson, 1999; Halliwell and Gutteridge, 2007).  
Single ortho-substituted PCBs and PCB mixtures such as Araclor 1242 have shown to induce 
ROS formation in human neutrophil granulocytes (Voie et al., 1998; Voie et al., 2000; 
Myhre et al., 2003; Myhre et al., 2009).  For this reason, neutrophil granulocytes were 
chosen for the study of PCBs also in this case. Human neutrophil granulocytes make good 
models for the study of ROS production after toxicant exposure, as they are both easy to 
isolate and available in great numbers. 
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There have been no published studies on effects of penitrem A in human neutrophil 
granulocytes. However, as it was observed in the cerebellar granule cell experiments that the 
antioxidant vitamin E gave protection against penitrem A-induced cell death, it was found 
interesting to see if penitrem A would induce ROS production in human neutrophil 
granulocytes. Cavanagh et al. (1998) described changes resembling ischemic damage in the 
cerebellum after in vivo penitrem A toxicity studies in rats. As mentioned, ROS have been 
suggested as an important factor contributing to cell damage during ischemia (Myhre et al., 
2003). 
1.6.2 Detection of reactive oxygen species in vitro 
For the most complete detection of ROS formation in biological systems such as the human 
neutrophil granulocytes, a combination of different techniques should be used. There are 
different techniques available that are specific for different kinds of ROS. Two techniques 
that may be used are the 2’,7’-dichlorodihydrofluorescein (DCF) assay and the 5-amino-2,3-
dihydro-1,4-phthalazindione (luminol)-amplified chemiluminescence assay (Myhre et al., 
2003).  
 
2’,7’-dichlorodihydrofluorescein diacetate (DCFH-DA) is a nonpolar, non-ionic probe that 
diffuses into the cell through the cell membrane, and is hydrolyzed by intracellular esterases 
to the nonfluorescent compound DCFH. DCFH may be oxidized to its strongly fluorescent 
form DCF in the prescence of ROS (LeBel et al., 1992; Myhre et al., 2003). DCF is often 
used as a general indicator of oxidative stress in cells, as it detects the presence of various 
ROS (Wang and Joseph, 1999). Myhre et al. (2003) found that it was sensitive to oxidation 
by ONOO
-
, 
•
OH, H2O2 in the combination with cellular peroxidases, and peroxidases alone. 
•
OH and ONOO
- 
may act within seconds or minutes, whereas other oxidants require more 
time (Myhre et al., 2003). 
Luminol is a dye that is able to penetrate the cell membrane. It releases energy in the form of 
a blue light when it is being excited by ROS (Dahlgren and Karlsson, 1999). This light may 
be measured in a luminometer and used as a measure of ROS formation. Chemiluminescence 
in the presence of luminol is dependent on the myleoperoxidase-H2O2 -Cl
- 
system (Myhre et 
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al., 2003; Halliwell and Gutteridge, 2007) and detects the presence of HOCl (Myhre et al., 
2003). 
1.6.3 Lactate dehydrogenase assay 
Lactate dehydrogenase (LDH) is a cytoplasmic oxireductase, which converts pyruvate to 
lactate in the prescence of reduced nicotinamide adenine dinucleotide (NADH). Leakage of 
this enzyme is a useful marker for cell damage (Koh and Choi, 1987). The LDH assay has 
been used to assess integrity of human neutrophil granulocytes (Reistad and Mariussen, 
2005; Reistad et al., 2005; Aam and Fonnum, 2007). LDH released from cells may be 
assessed in an assay where lactate, NAD
+
, resazurin and diaphorase are supplied. Lactate is 
converted to pyruvate through the action of LDH, and NAD
+
 is reduced to NADH. Resazurin 
is then converted to the fluorescent resorufin by diaphorase, and NADH is oxidized to 
NAD
+
. Fluorescence may then be measaured in a fluorometer. The generation of resorufin is 
proportional to the amount of extracellular LDH present (Promega Corporation, 2009). 
1.7 Cytoprotective agents and inhibitors of ROS production 
To elucidate mechanisms involved in cytotoxicity of cerebellar granule cells, as well as ROS 
formation in human neutrophil granulocytes in vitro, different pharmacological substances 
may be used. In this study, the following substances were used in the cerebellar granule cell 
PCB 52/180-experiments: (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-
imine maleate (MK-801), 1-amino-3,5-dimethyladamantane (memantine), cyclosporine A 
(CsA), 1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene (U0126), N-ω-nitro-
L-arginine methyl ester (L-NAME), α-tocopherol (vitamin E) and 1,2-bis-(o-aminophenoxy)-
ethane-N,N,N’N’-tetraacetic acid tetraactoxymethyl ester (BAPTA-AM).  
In the cerebellar granule cells studies involving penitrem A, the above mentioned substances 
were also used, with the exception of memantine. Additional substances tested with penitrem 
A include 2,3-dihydroxo-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX), glycine, 
diazepam, gamma-aminobutyric acid (GABA), bicuculline, phenobarbital, pentobarbital, 
alphaxalone, allopregnanolone, 4-[4-fluorophenyl]-2-[4-methylsulfinylphenyl]-5-[4-pyridyl]-
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1H-imidazole (SB203580), anthra[1,9-cd]pyrazol-6(2H)-one (SP600125) and tacrolimus 
(FK-506).  
In the human neutrophil granulocyte PCB experiments the following substances were used: 
CsA, U0126, vitamin E, FK-506, SB203580, SP600125 and BAPTA-AM. The same 
substances, as well as L-NAME, were used for penitrem A granulocyte experiments. 
L-glutamate is the main excitatory neurotransmitter in the brain. In addition to metabotropic 
receptors, there are three kinds of ionotropic glutamate receptors. The latter include the N-
methyl-D-aspartate (NMDA) receptor, which contributes a slow component to the excitatory 
synaptic potential, the α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) 
receptor, and the kainate receptor involved in fast excitatory synaptic transmission (Rang et 
al., 2007). 
Memantine and MK-801 are antagonists of the NMDA receptor ion channel (Wong et al., 
1986; Bormann, 1989). Memantine is less potent than MK-801 (Weller et al., 1993). NBQX 
is a selective antagonist of the AMPA and kainate receptors (Sheardown et al., 1990). The 
NMDA receptor requires glycine in addition to glutamate to be activated. Glycine also acts 
as an inhibitory neurotransmitter, primarily in the spinal cord, and also to some extent in the 
brain stem, where it acts on glycine receptors (Rang et al., 2007).  
GABA is the main inhibitory neurotransmitter in the brain. There is one ionotropic GABA 
receptor called the GABAA receptor, which has got several subtypes, and one metabotropic 
receptor called the GABAB receptor. The GABA A receptor has several binding sites for 
centrally acting drugs (Rang et al., 2007), which are presented in figure 1.5.  
GABA itself is the most important endogenous agonist in the body, acting on the GABA 
binding site (Johnston, 1996). Binding of GABA to its site will open the ion channel within 
the receptor and allow for influx of Cl
- 
ions, hyperpolarizing the cell (Rang et al., 2007). 
Bicuculline is a convulsant that blocks synaptic inhibition by GABA receptors by 
antagonising the action of GABA at the GABA binding site (Johnston, 1996; Rang et al., 
2007).  
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Figure 1-5. The GABA receptor with binding sites for agonists and antagonists used in the cerebellar 
granule cell experiments. Adapted from Moldes-Anaya (2010). 
GABAA receptors contain several sites where allosteric modulators may bind that affect the 
effect of the agonist (Johnston, 1996). Benzodiazepines, such as diazepam, potentiate the 
effect of GABA on the GABAA receptor. Binding of these agonists to the benzodiazepine site 
facilitates the binding of GABA to its site (Rang et al., 2007) and increases the opening 
frequency of the chloride channels within the receptor (Johnston, 1996). Barbiturates such as 
pentobarbital and phenobarbital increase the mean duration of the opening of the GABAA 
receptor chloride channels (Rang et al., 2007). Neurosteroids, such as alphaxalone and 
allopregnanolone, in general enhance the activation of GABAA by GABA by increasing the 
average opening time of the chloride channels, and also by increasing the opening frequency 
(Johnston, 1996). 
The fat-soluble vitamin E is a minor constituent of biological membranes. It is thought to be 
important in the preservation of membrane integrity by protecting polyunsaturated fatty acids 
of the membrane from oxidation. Its antioxidant action is fast and non-enzymatic and its 
prime role is believed to be scavenging lipid peroxyl radicals (Wang and Quinn, 2000). It has 
also been found to be involved in the scavenging of singlet oxygen (
1
O2) (Kaiser et al., 1990) 
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and reactions with ONOO
-
 (Hogg et al., 1994) and O2
•-
 (Ha and Csallany, 1992). Vitamin E 
has also been found to inhibit PKC (Wang and Quinn, 2000). 
L-NAME is a nitric oxide synthase (NOS) inhibitor (Moncada and Higgs, 1991). 
Five MAPK families have been identified in mammals. These are ERK 1/2, ERK 3/4, JNK, 
p38 and ERK 5 (Schaeffer and Weber, 1999; Chen et al., 2005). U0126 is a specific inhibitor 
of the MEK1/2 that phosphorylate and activate ERK1 and ERK2 (Favata et al., 1998). It also 
inhibits MEK 5, which acts upstream of ERK 5 (Kamakura et al., 1999). SB203580 is a cell 
permeable, selective inhibitor of the p38 pathway (Cuenda et al., 1995), whereas SP600125 
is a cell permeable, potent, reversible inhibitor of JNK (Bennett et al., 2001). FK-506 and 
CsA are immunosuppressant agents that complex with an immunophilin and inhibit the 
protein phosphatase calcineurin (Schreiber and Crabtree, 1992; Matsuda et al., 1998). They 
also inhibit the p38 and JNK pathways (Matsuda et al., 2000). CsA also inhibits opening of 
mitochondrial transition pores in the inner mitochondrial membrane (Bernardi et al., 1994). 
BAPTA-AM is an ester of the Ca
2+
 chelator BAPTA. Due to the presence of four 
acetomethyl (AM) groups in the molecule, BAPTA-AM may cross the cell membrane. Once 
in the cytosol, esterases cleave the AM groups, and the chelator is effectively trapped inside 
the cell where it may bind intracellular free Ca
2+
 and inactivate PKC (Dieter et al., 1993; 
Ndountse and Chan, 2009). 
1.8 Aim of study 
The aim of this study was to assess whether there was a difference in neurotoxicity in 
cerebellar granule cells between low and highly chlorinated ortho-substituted PCBs in vitro, 
and to identify possible factors involved in their neurotoxicity. The neurotoxic potential of 
penitrem A was also investigated along with potential factors involved. Further it was 
investigated if there was a difference in the ability of the PCBs to induce ROS production in 
human neutrophil granulocytes in vitro, and to identify possible pathways involved in this 
induction. The ROS production after penitrem A exposure was also assessed, as was 
potential pathways involved.   
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2. Materials and methods 
2.1 Chemicals  
2.1.1 Chemicals for the cultivation of cerebellar granule cells and 
the MTT assay: 
Chemical Abbreviation Producer  
Albumin from bovine serum, lyophilized 
powder ≥ 96 % (agarose gel 
electrophoresis) 
BSA Sigma-Aldrich, St. Louis, MO, 
USA 
Basal medium Eagle (1X), liquid, with 
Earle’s salt, without L-glutamine 
BME Invitrogen (GIBCO), Norway 
Cytosine β-D-arabinofuranoside – 
crystalline 
ARA-C Sigma-Aldrich, St. Louis, MO, 
USA 
Deoxyribonuclease I from bovine 
pancreas 
DNAse Sigma-Aldrich, St. Louis, MO, 
USA 
Dimethyl sulfoxide, bioreagent for 
molecularbiology, ≥ 99.9% 
DMSO Sigma-Aldrich, St. Louis, MO, 
USA 
Foetal bovine serum (heat inactivated) FBS Invitrogen, (GIBCO) Norway 
Glutamax-I supplement, 200 mM  Invitrogen, Norway 
Penicillin-streptomycin, liquid, 100 IU/ml 
penicillin, 100 µg/ml streptomycin 
 Invitrogen, Norway 
Phenol red, powder, bioreagent, cell 
culture tested 
 Sigma-Aldrich, St. Louis, MO, 
USA 
Poly-L-lysine hydrobromide, molecular 
weight >70,000 
 Sigma-Aldrich, St. Louis, MO, 
USA 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide 
MTT Sigma-Aldrich, St. Louis, MO, 
USA 
Trypsin type I from bovine pancreas, 
10,000 BAEE units/mg protein 
 Sigma-Aldrich, St. Louis, MO, 
USA 
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Trypsin inhibitor from Glycine max 
(soybean), type I-S lyophilized powder 
 Sigma-Aldrich, St. Louis, MO, 
USA 
 
2.1.2 Chemicals for the isolation and experiments with human 
neutrophil granulocytes: 
Chemical Abbreviation Producer 
Dextran   
2’,7’- dichlorodihydrofluorescein diacetat DCFH-DA Invitrogen, Norway 
Hanks’ Balanced Salt Solution  (10X), 
liquid 
HBSS Invitrogen (GIBCO), Norway 
HEPES buffer solution 1M, liquid HEPES Invitrogen, (GIBCO) Norway 
5 amino-2,3-dihydro-1,4-phthalazindione 
≥ 97 % (HPLC) 
Luminol  Sigma-Aldrich, St. Louis, MO, 
USA 
Lymphoprep, density gradient medium  Medinor, Norway 
Methanol, Chromasolv, gradient grade, 
for HPLC, ≥99.9% 
 Sigma-Aldrich, St. Louis, MO, 
USA 
CytoTox-ONE    Promega, Madison, WI, USA 
TRITON-X  Promega, Madison, WI, USA 
2.1.3 Test chemicals 
Chemical Systematic (IUPAC) name Abbreviation Producer 
Synthetic vitamin 
E≥ 96% (HPLC) 
α-tocopherol Vitamin E Sigma-Aldrich, 
St. Louis, MO, 
USA 
BAPTA-AM 
(intracellular Ca
2+
 
chelator) ≥ 95% 
(HPLC) 
1,2-bis(o-aminophenoxy)-ethane-
N,N,N′,N′-tetraacetic acid 
tetraacetoxymethyl ester  
BAPTA-AM Calcibiochem, 
San Diego, USA 
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Cyclosporine A - 
≥98.5% (TLC) 
 
(3S,6S,9S,12R,15S,18S,21S,24S,
30S)-30-ethyl-33-[(1R,2R,4E)-1-
hydroxy-2-methylhex-4-en-1-yl]-
1,4,7,10,12,15,19,25,28-
nonamethyl-6,9,18,24-tetrakis(2-
methylpropyl)-3,21-bis(propan-2-
yl)-1,4,7,10,13,16,19,22,25,28,31-
undecaazacyclotritriacontan-
2,5,8,11,14,17,20,23,26,29,32-
undecone 
CsA Sigma-Aldrich, 
St. Louis, MO, 
USA 
Tacrolimus 5,6,8,11,12,13,14,15,16,17,18,19,
24,25,26,26aS-hexahydro-5S,
19R-dihydroxy-3S-[(1E)-2-(4R-
hydroxy-3R-methoxycyclohexyl)-
1R-methylethenyl]-14S,16S-
dimethoxy-4R,10,12S,18R-
tetramethyl-8R-(2-propenyl)-15R, 
>99% 
FK-506 CAYMAN, 
Michigan, USA 
Glycine Glycine  Sigma-Aldrich, 
St. Louis, MO, 
USA 
Memantine 
hydrochloride 
1-amino-3,5-dimethyladamantane 
≥ 98% (GC) 
 Sigma-Aldrich, 
St. Louis, MO, 
USA 
MK-801 (BK 
channel blocker) 
(+)-5-methyl-10,11-dihydro-5H-
dibenzo[a,d]cyclohepten-5,10-
imine maleate  
MK-801 Sigma-Aldrich, 
St. Louis, MO, 
USA 
SB203580 (p38 
MAP kinase 
pathway inhibitor) 
4-[4-fluorophenyl]-2-[4-
methylsulfinylphenyl]-5-[4-pyridyl]-
1H-imidazole 
SB203580 Calcibiochem, 
San Diego, USA 
SP600125 (JNK 
inhibitor II) 
Anthra[1,9-cd]pyrazol-6(2H)-one SP600125  Calcibiochem, 
San Diego,  USA  
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U0126 1,4-diamino-2,3-dicyano-1,4-bis[2-
aminophenylthio]butadiene 
U0126 Promega, 
Madison, WI, 
USA 
L-NAME N-ω-nitro-L-arginine methyl ester L-NAME Sigma-Aldrich, 
St. Louis, MO, 
USA 
NBQX disodium 
salt 
2,3-dihydroxo-6-nitro-7-sulfamoyl-
benzo(F)quinoxaline 
NBQX Tocris 
Biosciences, 
Bristol, UK 
Penitrem A ≥ 
95% (TLC) 
  Sigma-Aldrich, 
St. Louis, MO, 
USA 
Diazepam 7-chloro-1-methyl-5-phenyl-3H-
1,4-benzodiazepin-2(1H)-one 
 Sigma-Aldrich, 
St. Louis, MO, 
USA 
GABA γ-aminobutyric acid  Sigma-Aldrich, 
St. Louis, MO, 
USA 
Bicuculline 
methochloride ≥ 
99 % 
[R-(R*,S*)]-5-(6,8-dihydro-8-
oxofuro[3,4-e]-1,3-benzodioxol-6-
yl)-5,6,7,8-tetrahydro-6,6-
dimethyl-1,3-dioxolo[4,5-
g]isoquinolinium chloride 
 Tocris 
Biosciences, 
Bristol, UK 
Phenobarbital  5-ethyl-5-phenyl-2,4,6-
pyrimidinetrione, 5-ethyl-5-
phenylbarbituric acid 
 Sigma-Aldrich, 
St. Louis, MO, 
USA 
Pentobarbital 
sodium salt 
5-ethyl-5-(1-methylbutyl)-2,4,6-
trioxohexahydropyrimidine 
 Sigma-Aldrich, 
St. Louis, MO, 
USA 
Alphaxalone 
≥ 99 % 
(3α,5α)-3-hydroxypregnane-11,20-
dione 
 Tocris 
Biosciences, 
Bristol, UK 
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Allopregnanolone (3α,5β)-3-hydroxy-pregnan-20-
one 
 Tocris 
Biosciences, 
Bristol, UK 
Ethanol    Sigma-Aldrich, 
St. Louis, MO, 
USA 
 
The ortho-substituted PCBs 28, 52, 101, 110, 153 and 180 were gifts from Patrick 
Andersson, Department of Chemistry, University of Umeå, Sweden. The PCBs had been 
chemically purified to remove any traces of coplanar, dioxin-like PCBs such as PCB 126.   
All other reagents used were analysis grade laboratory chemicals from standard commercial 
suppliers. 
Stock solutions of the PCBs and penitrem A, were prepared by dissolution in DMSO. 
Allopregnanolone, alphaxalone, CsA, FK-506, U0126, SB203580, SP600125, BAPTA-AM 
and vitamin E were also dissolved in DMSO. L-NAME was dissolved in PBS with pH 7.4. 
NBQX, pentobarbital and bicuculline were dissolved in distilled water, whereas MK-801, 
memantine and glycine were dissolved in Millique water. Phenobarbital was dissolved in 
Ethanol. 
2.2 Laboratory animals 
Rats used for cultivation of cerebellar granule cells were at the start of the study purchased 
from Scanbur, Sweden. However, after a viral infection in the rat population of the supplier, 
animals were for the rest of the study purchased from Tactonic, Denmark. 
Mixed sex litters of ten Wistar rat pups, 7 days of age, were delivered with a surrogate 
mother at the day of cell culture preparation. The rats were housed in the animal department 
for no longer than 2 hours prior to euthanasia. 
The surrogate mother was euthanized by the use of CO2 and decapitation. The rat pups were 
decapitated without the prior use of anaesthesia.  
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2.3 Cerebellar granule cell experiments 
2.3.1 Cultivation of cerebellar granule cells 
Primary cultures of cerebellar granule cells were prepared largely corresponding to the 
method described by Gallo et al. (1982). 
Each week, on the day preceding cell cultivation, appropriate solutions (1-4) were prepared 
(see appendix), and sterilely filtrated through 0.22 µm filters (Sarsted, Nümbrecht, 
Germany). 12-well multi-dish plates (Nunc) were pre-treated for at least 1 hour with 1 ml per 
well of 0,01mg/ml poly-L-lysine solution to ensure attachment of the cells to the bottom of 
the wells. 500 ml of medium for cell cultivation was prepared, and kept in the refrigerator for 
up to 4 weeks. This consisted of basal Eagle’s medium supplemented with 10 % heat 
inactivated foetal bovine serum, 2,5 mM Glutamax, 100 IU/ml penicillin + 100 µg/ml 
streptomycin (P/S), 25 mM potassium chloride (KCl) and 1% glucose. All the above stages 
were carried out aseptically in a laminar air flow (LAF) cabinet (Holten Laminar Air). 
At the day of cell cultivation, the 7 day old rat pups were euthanized at the animal 
department premises by decapitation. The heads were kept on ice, and dipped in 70 % 
ethanol prior to removal of the cerebellum. When dissected out the cerebellum was put in a 
sterile 50 ml conical red top tube (Sarsted, Nümbrecht, Germany) with 10 ml solution 1, 
containing magnesium sulphate (MgSO4) and bovine serum albumin (BSA). 
Back at the laboratory, the rest of the cultivation procedure was carried out aseptically in the 
LAF cabinet. Meninges and blood vessels were dissected away from the cerebellum, and the 
clean tissue put in fresh solution 1. The cerebelli were cut in 3-4 pieces using a scalpel blade 
and transferred to a 15 ml conical red top tube (Sarsted, Nümbrecht, Germany). The tube was 
then centrifuged for 1 minute at 1000 revolutions per minute (rpm) in a table centrifuge 
(Heraeus, Megafuge 1.0).  
After centrifugation the supernatant was removed, and 10 ml solution 2 containing trypsin 
was added. The re-suspended cerebellar pieces and solution were then transferred to a 250 ml 
Erlenmeyer flask, which was placed in an incubator shaker (Innova 4000) for 15 minutes at 
approximately 60 rpm and 37 °C. This trypsinization stage was carried out to dissolve 
adhesions between cells in order to obtain individual cells for the next stages of cultivation. 
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It was important that the trypsinization was not extended for longer than indicated, as this 
could have caused damage to the cells.  
After the end of the trypsinization, the dissolved cerebellar tissue was removed from the 
flask with as little solution 2 as possible. It was then re-suspended in a new 15 ml tube, in 
approximately 10 ml of solution 4 (a dilution of solution 3), containing trypsin inhibitor and 
deoxyribonuclease (DNAse). The trypsin inhibitor ends the action of trypsin, whereas the 
DNAse prevents lumping of DNA released from cells dying during the cultivation process. 
The tube was then centrifuged for 1 minute at 1000 rpm. This stage was repeated if 
necessary, until there was a clear distinction between the pellet and the supernatant.  
In the following step the pellet was re-suspended in 3 ml of solution 3, and homogenization 
of the pellet was carried out by the use of a series of glass Pasteur pipettes, on which the 
openings had been made progressively smaller by the use of a bunsen burner. When a 
homogenous solution had been achieved, the tube was filled with 10 ml pre-prepared cell 
culture medium and centrifuged for 7 minutes at 900 rpm.  
The resulting pellet was then dissolved in 2 ml of medium and transferred to a 150 ml flask 
containing further medium. 125 ml medium was used for 10 rat pups and 10 multi-well 
dishes, ensuring 1 ml cell suspension per well, and a concentration of approximately 1-
1,2x10
6
 cells per ml. A 5 ml Pasteur pipette was used to transfer cells to the plates. The flask 
was rotated and the content mixed thoroughly every time a new volume was withdrawn. 
After being transferred to the plates, the cells were placed in an incubator at 36 ºC, in a 5 % 
CO2 atmosphere, for 7-9 days before being used in experiments.  
18-24 hours after placement in the incubator , 25 µl cytosine arabinofuranoside (ARA-C) 
dissolved in basal medium Eagle (BME) was added to each well, giving a concentration in 
the medium of 10,3 µM. ARA-C prevents the proliferation of non-neuronal glial cells, and 
ensures a relatively pure culture of granule cells. 
2.3.2 In vitro toxin exposure of cerebellar granule cells 
After 7 days of incubation the cerebellar granule cells were used for in vitro cell survival 
experiments with PCB and penitrem A. Preliminary studies were carried out with varying 
concentrations of PCB 52 and PCB 180 at 6, 12, 18 and 24 hours (results are not displayed) 
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before it was decided that cell survival experiments were to be carried out with 24 hours 
exposure to the toxins. For assessment of a dose-response relationship, exposure to the 
following doses was included: 2.5, 5, 10, 12.5, 15, 20 and 30 µM PCB 52 and 180. 
In experiments aimed at elucidating mechanisms involved in PCB 52 and PCB 180 
cytotoxicity, incubation of PCBs was carried out with potentially neuroprotective substances. 
The following substances and concentrations were tested: 3 µM MK-801, 3 µM memantine, 
0.5 µM CsA, 50 µM vitamin E, 10 µM U0126, 300 µM L-NAME, 1 µM BAPTA-AM, and 5 
µM BAPTA-AM. The concentrations of the potentially neuroprotective substances were 
selected based on what was found in the literature. 
Each of these substances was tested in conjunction with 20 µM PCB 52 and PCB 180. Due 
to the fact that 20 µM PCB 180 alone caused quite high toxicity, it was chosen to test the 
neuroprotective agents considered most likely to give effect also in conjunction with 15 µM 
PCB 180. This was done because it was considered likely that the high degree of cell death 
caused by 20 µM PCB 180 could be difficult to influence by adding protective agents. 
In addition to the above mentioned studies of PCB 52 and PCB 180, cells were exposed to 
10, 12.5 and 15 µM PCB 28, 52, 101, 110, 153 and 180 for 24 hours. This was done to 
assess differences in survival between cells exposed to the same concentration of different 
PCBs, and difference in cell survival exposure to different concentration of the same PCB. 
Cerebellar granule cells were also incubated for 24 hours with 2, 10, 12.5, 15, 20 and 40 µM 
penitrem A, in order to assess if there was a dose-response relationship. Also for penitrem A, 
incubation with neuroprotective substances was carried out for 24 hours to try to identify 
potential mechanisms involved in its toxicity. Each substance was tested in conjunction with 
12.5 µM penitrem A. As there have been no published studies of penitrem A toxicity in 
cerebellar granule cells, the concentrations of the substances tested were largely based on the 
concentrations of the same protective agents used in studies of PCB in cerebellar granule 
cells. The following substances and concentrations were used: 5 and 50 µM diazepam, 10 
and 50 µM GABA, 150 and 300 µM pentobarbital, 300 and 600 µM phenobarbital, 2 µM 
allopregnanolone, 2 µM alphaxalone and 50 µM bicuculline, 50 µM glycine, 20 µM NBQX, 
3 µM MK-801, 0.5 µM CsA, 10 µM U0126, 50 µM vitamin E, 300 µM L-NAME, 1 µM 
SB203580, 10 µM SP600125, 1.5 µM FK-506, 0.5, 5 and 10 µM BAPTA-AM. 
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Cerebellar granule cells were also exposed to 12.5 µM penitrem A for 2, 6, 8, 12 and 24 
hours, in order to see if there was a time-related increase in toxicity. A DMSO control, 12.5 
µM penitrem A and 12.5 µM penitrem A with 50 µM vitamin E were tested in each 
experiment. 
In each experiment, the different drug concentrations or combinations of drug and 
neuroprotective agent were tested in triplicate and an average value was calculated for each 
triplicate. At least two triplicates of controls only containing medium and two triplicates of 
controls containing dimethyl-sulphoxide (DMSO) were always included in the experiments. 
As PCBs and certain protective agents were dissolved in DMSO, DMSO controls were 
included to ensure that the solvent did not exert any toxic effects on the cerebellar granule 
cells in its own right during an experiment. The amount of DMSO included in the DMSO 
control wells corresponded to the highest concentration cells were exposed to due to addition 
of PCBs and/or protective agents. The DMSO concentration never exceeded 0.3%, as a 
higher concentration could be toxic to the cells (Mariussen E., personal communication 
2009). 
Little variability was found in cell survival between control wells both within and between 
plates when assessed by the MTT assay (described in 2.5). Therefore, results were analysed 
together for all 120 wells (10 plates), and each well was treated as a separate instance 
regardless of which one of the 12 plates it was located on. 
15 ml red top conical tubes, containing 3.5 ml medium, were prepared prior to the 
experiment and heated in an incubator shaker. The medium was prepared as described in 
section 2.3.1, but without foetal bovine serum. Serum was not included as albumin may will 
bind PCB and reduce the response. (Fonnum F., personal communication, 2009) The 
appropriate amounts of the test substances were added to a tube containing 3.5 ml medium in 
order to obtain the desired concentration in the control wells. The tube was then vortexed 
vigorously just prior to application to prevent test substances from sticking to the sides of the 
plastic tube. When inhibitors were included, these were added at the same time as the toxins. 
During the experiment, plates were removed one at the time from the 36ºC, 5% CO2 
incubator, and exposed to the toxins and inhibitors dissolved in medium. The original 
medium from the wells was removed carefully from 3 wells at the time, and 1 ml test 
solution applied immediately to each well to prevent the wells from drying out. Once this 
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had been carried out for the whole plate, it was put back into the incubator for the determined 
time period. The procedure was carried out aseptically in the LAF cabinet. 
2.3.3 MTT cell survival assay 
Once the cells had been exposed to the toxins and neuroprotective substances for the 
appropriate amount of time, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide (MTT) assay was used for measurement of cell survival. The assay was carried out 
according to the protocol developed by Tim Mosmann (1983), with modifications. 
0,5 mg/ml of yellow MTT solution with 1 % glucose was prepared by dissolution of the solid 
powder in phosphate buffered saline (PBS), and sterilely filtrated through 0,22 µm filters 
(Sarsted, Nümbrecht, Germany) in the LAF cabinet. Appropriate amounts of solution were 
transferred into sterile 50 ml conical red top tubes, wrapped with aluminium foil and frozen. 
At the day of the assay, tubes of MTT solution were thawed in the incubator shaker and pre-
warmed to 37º C before addition to the cell culture plates. As during the exposure stage 
described in 2.3.2, one plate at the time was removed from the 36º C, 5 % CO2 incubator. 
Medium was removed carefully from 3 wells at the time using a glass Pasteur pipette and a 
Pipetboy, and 0.5 ml MTT solution added to the wells. All plates were then returned to the 
incubator for exactly one hour before they were transferred to a fume hood. The MTT 
solution was then removed and 0.5 ml DMSO added to the wells. A few minutes were 
allowed for the purple formezan salts that had been created to be completely dissolved in 
DMSO. 100 µl of the resulting purple coloured solution were pipetted in duplicate from each 
well onto a 96-well transparent, flat bottom tissue culture plate (Sarstedt, USA). 
Absorbance values were then obtained spectrophotometrically by the use of a multi-well 
ELISA reader (Labsystem Multiscan Biochromatic, type 348). Dual wavelength 
measurements were performed at 570 nm (test wavelength) and 690 nm (reference 
wavelength). Values from the reference wavelength were subtracted from the test wavelength 
by the machine to obtain the final absorbance values. The plates were read as soon as 
possible after completion of the experiment. 
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2.4 Human neutrophil granulocyte experiments 
2.4.1 Isolation of human neutrophil granulocytes 
Isolation of human neutrophil granulocytes for reactive oxygen species (ROS) measurements 
was carried out by dextran sedimentation and density gradient centrifugation, as described by 
Bøyum et al. (1991). Blood from different healthy, non-smoking, male volunteers was 
collected in the morning on the day of the experiment. Approximately 50 ml of blood were 
withdrawn from each subject. EDTA coated Vacuette tubes (Med-Kjemi AS, Norway) were 
used to prevent coagulation of the blood. 
The blood was divided into two 50 ml conical red top tubes, and 1 ml 6% dextran in 0.9% 
NaCl per 10 ml blood was added to each tube. The tubes were turned gently a few times and 
allowed to stand for 30 minutes at room temperature for the erythrocytes to settle at the 
bottom of the tubes. After sedimentation of the erythrocytes, approximately 10 ml of 
leukocyte rich supernatant was removed from the tubes and transferred to two 15 ml conical 
red top tubes. Subsequently, 3 ml of the isoosmotic separation medium Lymphoprep was 
added to the bottom of each tube using a long 21 gauge 150 mm needle. The tubes were 
centrifuged at 1900 rpm for 15 minutes at room temperature in a table centrifuge (Heraeus, 
Megafuge 1.0). This caused the formation of a layer of monocytes at the interface between 
the supernatant and the separation fluid, whereas a pellet consisting of neutrophils and 
remaining erythrocytes was formed at the bottom of the tube. 
In the next step supernatant, separation medium and the layer of monocytes, was carefully 
removed by the use of a plastic pipette. The cells were re-suspended in 5 ml 0.83 % NH4Cl, 
and left at room temperature for 7 minutes for lysis of the remaining erythrocytes. The tubes 
were then centrifuged for 7 minutes at 1900 rpm. If the lysis of red blood cells at this stage 
was incomplete, the preceding step was repeated as many times as considered necessary. 
After centrifugation the supernatant was removed, and each of the two pellets was re-
suspended in 5 ml 0.9% NaCl washing solution. The tubes were centrifuged again at 1900 
rpm for 7 minutes, the supernatant removed, and the two pellets dissolved in 6 ml 1x Hanks’ 
Balanced Salt Solution (HBSS) buffer supplemented with 4.17 mM NaHCO3, 20 mM 
HEPES and 5 mM glucose (from now on only referred to as HBSS buffer). The resulting 12 
ml of cell suspension were then transferred to a single 15 ml conical red top tube, and the 
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number of cells counted in a coulter counter (Coulter Electronics Ltd., Harpenden, Harts, 
England). The cells were then diluted in HBSS buffer to a concentration of 2.5 million 
cells/ml buffer. The diluted cells were kept at room temperature, or in the refrigerator if time 
was long from isolation of cells to the start of the experiments.  
2.4.2 Measurement of reactive oxygen species after exposure to 
toxic substances 
ROS formation may be measured by several techniques, of which two are the DCF and the 
luminol amplified chemiluminescence assays. After preparation as described in 2.4.1, cells 
were exposed to different concentrations of the 3 ortho-substituted PCBs (PCB 52, PCB 153 
or PCB 180), and to the mycotoxin penitrem A. In addition 20 µM of the 3 different PCBs 
and 10 µM penitrem A were tested in combination with different chemicals known to inhibit 
intracellular pathways leading to the formation of ROS. These inhibitors were also tested 
alone to elucidate effects on basal ROS production in unstimulated cells.  
Stock solutions of the toxic substances PCB and penitrem A, as well as the potential 
inhibitors of ROS production, CsA, FK-506, U0126, SB203580, SP600125, BAPTA-AM 
and vitamin E were prepared by dissolution in DMSO. L-NAME was dissolved in PBS with 
pH 7.4. Different concentrations of toxic substances, combinations of toxic substances and 
ROS inhibitors as well as ROS inhibitors alone were added to white 96 microwell plates 
(Nunc A/S Denmark) in triplicate prior to the addition of cells. 
The final concentration of DMSO in each well, after addition of cells and buffer, would be 
0.2 or 0.4 % per well in the wells with toxic substance and with toxic substance and 
inhibitor, respectively. As DMSO seemed to decrease basal ROS levels in un-stimulated 
control cells substantially, especially in the fluorescence experiments, DMSO controls with 
the same amount of DMSO as found in the experimental wells (0,5 µl or 1 µl) were included 
in each experiment in triplicate at two different sites of the plate. This was done to be able to 
correct for the suppressive effect of DMSO on ROS production at the different 
concentrations of toxic substances/combinations of toxic substances and inhibitors, and for 
the subsequent calculation of relative fluorescence/chemiluminescence values, as percentage 
of DMSO control. Much higher levels of fluorescence/luminescence were detected in 
unstimulated controls than in blank wells. This was assumed to reflect basal ROS production 
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in the unstimulated neutrophil granulocytes. As values were calculated as percentage of the 
DMSO controls, the use of the term basal ROS levels will in the following parts of this thesis 
refer to the level of ROS in cells only treated with DMSO. 
In each experiment, three wells only containing HBSS buffer (blank) were included to 
correct for background fluorescence/luminescence, thus allowing subtraction of the blank 
value from the results. No positive control was included in the PCB experiments, due to the 
fact that PCB 153 has been studied before and has been shown to induce ROS production 
(Reistad and Mariussen, 2005). 
In the case of penitrem A, preliminary studies with 10 µM, were conducted in the same 
studies as the PCBs. Due to the fact that penitrem A caused significantly higher ROS 
production than PCB 153 when measured by the DCF assay, no positive control was 
included in following studies where penitrem A was studied alone. Only preliminary luminol 
chemiluminescence studies were carried out for penitrem A, as luminescence in cells after 10 
µM exposure was not found to be significantly different from control. 
2.4.3 Detection of ROS with the DCF assay 
The assessment of ROS by the DCF assay was carried out mainly as described by Myhre et 
al. (2000) and Aam and Fonnum (2006), with slight modifications. 150 µl of HBSS buffer 
was added to each well of the 96 micro well plate, except for in wells containing the blank, 
where 250 µl buffer was added. The appropriate amount of toxic substance and ROS 
inhibitors was then added to each well, and the plate covered by aluminium foil.12 ml of cell 
suspension was divided into three 15 ml red top tubes, with 4 ml suspension in each tube. 
Subsequently, 0.16 µl 5 mM stock solution of DCFH-DA in methanol was added to each 
tube (0.4 µl per 1 ml of cells), giving a final concentration of 2 µM DCFH-DA in the cell 
suspension. The tubes were then covered with aluminium foil to protect the probe from light, 
and incubated for 15 minutes at 37°C in a water bath. Subsequently, the tubes were 
centrifuged for 7 minutes at 1900 rpm, the supernatant removed, and replaced by 4 ml HBSS 
buffer. The cells were resuspended in the buffer, and 100 µl of cells were added with a 
multipipette to all the wells of the plate, with the exception of the wells containing the blank. 
DCF fluorescence was then measured every other minute for 120 minutes, in a microplate 
spectrofluorometer (Molecular Devices, SpectraMax Gemini EM), and the area under the 
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curve (AUC) calculated. Values were for statistical purposes expressed as fluorescence 
relative to DMSO control, set to 100 %.  
2.4.4 Detection of ROS with the luminol chemiluminescence assay 
Detection of ROS formation by the luminol-amplified chemiluminescence assay was 
performed as described by Voie et al. (1998) and Aam and Fonnum (2006) with 
modifications. 50 µl of HBSS buffer was added to each well of the 96 microwell plate, with 
the exception of the blank triplicate where 250 µl was added. The appropriate amounts of 
toxic substances and toxic substance/inhibitor combinations were added, and the plate 
covered with aluminium foil. 10 ml of 0.25 mM luminol in HBSS was prepared in a 15 ml 
red top tube by dissolution of 25 µl of the 0.1 M stock solution of luminol in DMSO in 9.975 
ml HBSS. As luminol is light sensitive, the tube was covered with aluminium foil. 100 µl of 
luminol solution followed by 100 µl of cell suspension was then added to the microwell 
plate, with the exception of the blank. The final concentration of luminol in each well was 
0.1 mM. Luminescence was measured every other minute for 1 hour in a multidetection 
microplate reader (BioTek Instrument’s Synergy 4 Multidetection Microplate Reader), and 
the AUC was calculated. Values were for statistical purposes expressed as luminescence 
relative to DMSO control, which was set to 100 %.  
2.4.5 LDH assay 
Assessment of cell integrity after exposure of human neutrophil granulocytes to 10 µM 
penitrem A and 20 µM of the different PCBs was done with the LDH homogenous 
membrane integrity assay CytoTox-ONE kit from Promega. Leakage of LDH is a useful 
marker for cell damage (Koh and Choi, 1987). 250 µl of cell suspension consisting of 100 µl 
cells and 150 µl HBSS buffer, was added to 1.5 ml Eppendorf tubes in conjunction with the 
toxic substances. Cells were exposed in triplicate for 2 hours as previously described for the 
DCF assay. Once the incubation time had expired, 200 µl of the cell mixture was transferred 
to new 1.5 ml Eppendorf tubes, and centrifuged at 15 000 g for in a bench centrifuge at room 
temperature for 3 minutes. (Sorvall, Refrigerated MicroCentrifuge-14). Subsequently, 100 µl 
of supernatant was transferred to a white 96 microwell plate, and 100 µl of the kit reagent 
containing lactate, NAD
+
, reazurin and diaphorase was added in darkness. After 10 minutes 
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of incubation the reaction was stopped by adding 50 µl of the kit stop solution, preventing 
further generation of fluorescent products. Resorufin fluorescence was measured at room 
temperature, in a multilabel counter (Victor 2, Perkin Elmer) at excitation and emission 
wavelengths of 530 nm and 580 nm, respectively. Included in the assay were wells only 
containing buffer (blank), negative control only containing buffers and cells, positive control 
containing 0.3 % Triton-X-100, and cells incubated with the toxic substances. Triton-X-100, 
lyses the cell membrane allowing for release of LDH.  Values were calculated as % LDH 
release as compared to control only containing buffer and cells.  
2.5 Statistical analyses 
In this section choice of statistical methods will be discussed in general. The methods 
applied in each individual case will be mentioned in the relevant context in the results 
section. Statistical analyses and calculations were carried out by the use of GraphPad Prism 
4, PASW Statistics 18 software and Microsoft Excel 2003. Graphical plots were made in 
GraphPad Prism 4, and in one case in Microsoft Excel 2003. 
Generally, data were analyzed in GraphPad Prism 4, where assessments for deviations from 
normality and homogeneity of variances between groups were made prior to statistical 
comparisons. These assessments, as well as the assumption that observations are independent 
are prerequisites that must be fulfilled prior to the use of ANOVA and its corresponding post 
hoc tests (Motulsky, 2003). 
The assumption that the experimental data come from a population with an approximate 
normal distribution was tested by use of Dallal and Wilkinson’s method (adapted from 
Lilliefors’ modified Kolmogorov-Smirnov test), and graphical depiction in box-plots. The 
same method was used to assess if the differences between each set of pairs come from a 
normally distributed population in case of the paired t-test. Dallal and Wilkinson’s method 
does not require prior knowledge of the mean and standard deviation of the overall 
population, as opposed to the original Kolmogorov-Smirnov test, and is the test for normality 
applied by GraphPad Prism 4 (Motulsky, 2003). No significant deviation from normality was 
found in the experiments conducted. 
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Homogeneity of variances between groups that were to be compared statistically, was in 
most cases assessed by Bartlett’s test. In the few cases where there were less than 4 
individual experimental values in one or several of the groups that were to be compared, 
homogeneity of variances was assessed by use of Levene’s test – followed by other 
appropriate tests in PASW – as GraphPad Prism does not perform the Bartlett’s test under 
such circumstances. 
For multiple pairwise comparisons between groups, in the cases where the above mentioned 
prerequisites were fulfilled, an ANOVA test was conducted and followed by an appropriate 
post hoc test if the null hypothesis (that there was no significant difference between the 
groups) was rejected. 
For comparison between the mean of a control group and the means of each of the different 
experimental groups that were tested in the ANOVA, a Dunnet’s post hoc test was chosen. 
Where multiple comparisons of the means of all the groups with each other were of interest a 
Tukey-Kramer test was performed. 
Also in certain cases a post hoc test for the detection of a linear trend was performed. This 
was used to determine whether the mean values of groups increase or decrease in a 
systematic manner along the x-axis. The test is based on a linear regression on group mean 
versus group number (in order of appearance from left to right) on the x-axis (Motulsky, 
2003). 
In the cases where there was found to be unequal variances between the different 
experimental groups, multiple pairwise comparisons were conducted by the use of a Welch 
test. A Games-Howell post hoc test was used if the null hypothesis (that there was no 
significant difference between the groups) was rejected. This was done in PASW Statistics 
18.  These tests do no require that variances in the groups are homogenous, and should avoid 
the increased risk of type 1 errors that may occur if tests that require equal variances are 
applied to data that violate these assumptions. Such a violation will especially produce a 
higher chance of type I errors if you have a small number of experiments (Games et al., 
1983; Zimmerman, 2004). 
As sample sizes are relatively small for the presented data, a non-parametric test such as the 
Kruskal-Wallis test was not considered to be the best choice when intra-group variances 
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were unequal. These tests have little power to detect differences when sample sizes are small 
(Motulsky, 2003).  
 
In all the cases where a toxin was studied with and without the addition of a neuroprotective 
substance or ROS inhibitor, a two-tailed, paired, Student’s t-test was applied to assess 
statistical differences. As above mentioned, the pairwise differences between treatments 
were tested for normality before the t-test was conducted. Due to the fact that a large number 
of neuroprotective substances/inhibitors were tested, it was not always possible to include all 
in the same experiment. This resulted in some variation in the value for the toxin tested 
alone, and is the reason why the value for the toxin alone has been presented together with 
the value for the toxin with each neuroprotective substance/inhibitor when graphically 
displayed in the results section.  
The neuroprotective substances and ROS inhibitors were always also tested alone (without 
PCBs or penitrem A) to see if they themselves had any significant effect on survival or basal 
ROS production, respectively. In the case of the cerebellar granule cells, results were 
compared to control, whereas they were compared to DMSO control in the human 
granulocyte experiments. This was either done by ANOVA followed by a Dunnet’s post hoc 
test or with a Welch test followed by a Games-Howell test, depending on normality and 
equality of variances.  
In the case of PCB 52 and PCB 180, best fit dose-response curves were obtained from the 
cerebellar granule cells experiments by non-linear regression in GraphPad Prism 4. The 
values that would kill half of the cell population (LC 50 values) were computed for the two 
PCBs, and the difference between them was tested for statistical significance by the program. 
For completion of this step concentration values on the x-axis were log transformed, whereas 
y-values were normalized to a common scale. The dose response curve for penitrem A and 
its LC50 value were obtained in the same manner. 
In all the experiments conducted a p-value of < 0.05 was regarded as statistically significant. 
In the following results section, exact p-values will be reported where this is available, 
otherwise p-values will be reported as p < 0.05, p <0.01 and p < 0.001. As a general rule, 
only values for results that were statistically significant have been reported in the results 
section, but in certain cases non significant values have been included for completeness. 
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Group means are reported as well as the standard error of the mean (SE). Confidence 
intervals are reported where this is found relevant. Where the unit of the mean value is 
percent of control, SE is given in percentage points, not as a relative percentage of the given 
mean. For simplicity of reading percentage points are in these cases represented by the 
symbol “%”. This applies if not otherwise specified.  
In the case of LC 50 values, deviations from mean are represented by confidence intervals 
(CI). As the LC 50 values are calculated from log values after fitting of the dose response 
curves it is not appropriate to back-calculate the SE, and GraphPAD Prism therefore reports 
the mean value and the 95 % confidence interval (Motulsky, 2003). 
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3. Results 
3.1 Neurotoxicity studies in cerebellar granule cells 
3.1.1 General considerations 
Cerebellar granule cells were exposed in triplicate to toxins and/or potentially 
neuroprotective substances. Neuroprotective substances were also tested alone (without 
toxins). Survival was assessed with the MTT assay, and calculated as percentage of control 
(set to 100 %), which only contained medium. This was done for all the cerebellar granule 
cells experiments for both PCB and penitrem A. 
For the PCB toxicity experiments, none of the neuroprotective substances caused a 
significant change in survival compared to control when cells were exposed to these alone. 
This was assessed using an ANOVA with a Dunnet’s post hoc test. One of the 
neuroprotective substances used in conjunction with penitrem A showed significant 
influence on survival also when used alone. This is discussed in the section on penitrem A 
and neuroprotective substances (3.1.6). 
DMSO controls, corresponding to the highest concentration of DMSO used in the 
experiment, were included in all experiments and did not cause any significant reduction in 
survival compared to control. This was the case in all the cerebellar granule cells 
experiments conducted for both PCB and penitrem A 
3.1.2 Comparison of PCB 52 and PCB 180  
Cerebellar granule cells were exposed in triplicate to 2.5, 5, 10, 12.5, 15, 20 and 30 µM PCB 
52 and PCB 180 for 24 hours (n = 6-12). Both PCB 52 and 180 showed a dose dependent 
decrease in survival with increasing concentration. For PCB 52 a concentration of 15 µM 
and higher showed a statistically significant reduction in survival compared to control, 
whereas for PCB 180 this was the case for concentrations from 10 µM and above. Dose 
response curves for PCB 52 and PCB 180 are presented in figure 3.1. 
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After exposure to PCB 52, survival was reduced to 46 ± 7 % (mean ± SE, p < 0.01) for 15 
µM, 21 ± 3 % (p < 0.001) for 20 µM and 3.0 ± 0.6 % (p < 0.001) for 30 µM. 
For PCB 180, survival was reduced to 45 ± 4 % (mean ± SE) for 10 µM, 31 ± 4 % for 12.5 
µM, 17 ± 4 % for 15 µM,  8 ± 1 % for 20 µM, and 2.4 ± 0.2 % for 30 µM (p < 0.001 for all). 
A Welch test with a Games-Howell post hoc test was used to assess statistical differences. 
The LC50 values for PCB 52 and PCB 180 were estimated to 14.3 (95 % CI [13.7, 15.0]) and 
9.5 (95 % CI [8.9, 10.1]) µM respectively, and found to be significantly different from each 
other (p < 0.0001). 
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Figure 3-1.Survival of cerebellar granule cells in vitro as percentage of control after 24 hours of 
exposure to 2.5, 5, 10, 12.5, 15, 20 and 30 µM PCB 52 and PCB 180. The concentration values are 
log-transformed. Survival data was assessed with the MTT assay. Survival values are presented as 
mean ± SE (n = 6-12 in triplicate). A Welch test with Games-Howell post hoc test was performed to 
assess if survival was statisticalyl different from control. For PCB 52, the significance levels are 
indicated as # = p < 0.05, ## = p < 0.01 and ### = p < 0.001. For PCB 180: * = p < 0.05, ** = p < 0.01 
and *** = p < 0.001. LC50 values for PCB 52 and 180 were estimated to 14.3 (95 % CI [13.7, 15.0]) 
and 9.5 (95 % CI [8.9, 10.1]) µM, respectively. 
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3.1.3 Effects of potentially neuroprotective substances on PCB 52 
and PCB 180 toxicity  
Cerebellar granule cells were incubated in triplicate with 20 µM PCB alone as well as in 
conjunction with one of several potentially neuroprotective substances for 24 hours. The data 
were compared with a two-tailed, paired Student’s t-test. 
20 µM PCB 52: Average survival after exposure to PCB 52 alone and in conjunction with 
the different neuroprotective agents is presented in figure 3-2. 
For 0.5 µM CsA, 10 µM U0126, 300 µM L-NAME and 3 µM memantine there was no 
significant difference between cells exposed to 20 µM PCB 52 in conjunction with the 
inhibitor and to PCB alone (n = 3-5). 
20 µM PCB with 50 µM vitamin E (n = 7), 3 µM MK-801 (n = 5) and 5 µM BAPTA-AM (n 
= 3) were significantly different from 20 µM PCB alone. Vitamin E caused an average 
increase in survival of 43 (95% CI [30, 57], p = 0.0002), MK-801 an increase of 17 (95% CI 
[9, 24], p = 0.0032), and BAPTA-AM a decrease of 24 (95% CI [6, 41], p = 0.0279) 
percentage points. 
As mentioned in 3.1.1, neuroprotective substances were also tested on cells alone (n = 3-5), 
but none caused a significant change in survival compared to control.  
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Figure 3-2. Survival of cerebellar granule cells after 24 hours of exposure to 20 µM PCB 52 and 
potentially neuroprotective substances in vitro. Survival was measured with the MTT survival assay. 
Mean survival of cells and SE are presented as percentage of control (n = 3-7 in triplicate). 
Differences in survival between groups were analysed with a two-tailed, paired Student’s t-test. The 
symbols *, **, and *** represent p < 0.05, p < 0.01 and p < 0.001, respectively. Cells were also 
exposed to neuroprotective substances alone (n = 3-5 in triplicate). No significant differences in 
survival were observed compared to control. An ANOVA with Dunnet’s post hoc test was used. 
20 µM PCB 180: The average survival in cerebellar granule cells after the exposure to 20 
µM PCB 180 with and without neuroprotective agents is shown in figure 3-3. 
Survival after incubation of cells with 20 µM PCB 180 alone was not significantly different 
from survival after incubation in conjunction with 10 µM U0126, 300 µM L-NAME, 3 µM 
memantine, 3 µM MK-801 or 1 µM BAPTA-AM (n = 3-7). 
Incubation with 0.5 µM CsA caused a small but statistically significant average increase in 
survival of 2.2 (95 % CI [0.5, 3.8], p = 0.0198) percentage points compared to PCB alone (n 
= 6). Vitamin E with 20 µM PCB 180 caused a significant average increase in survival of 24 
(95 % CI [19, 30], p = 0.0003) percentage points (n = 5). 
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Figure 3-3. Survival of cerebellar granule cells after 24 hours of exposure to 20 µM PCB 180 and 
potentially neuroprotective substances in vitro. Survival values were measured with the MTT survival 
assay. Mean survival of cells and SE is presented as percentage of control (n = 3-7 in triplicate). 
Differences in survival between groups were analysed with a two-tailed, paired Student’s t-test. The 
symbols *, **, and *** indicate p < 0.05, p < 0.01 and p < 0.001 respectively. Exposure to 
neuroprotective substances alone did not cause significant changes in survival compared to control (n 
= 3-5 in triplicate). An ANOVA with Dunnet’s post hoc test was used. 
15 µM PCB 180: The average survival values for 15 µM PCB 180 with and without 
inhibitors are displayed in figure 3-4. 
There was no statistically significant difference in survival when cells were incubated with 
PCB and 3 µM memantine or with 15 µM PCB 180 alone (n = 3). 5 µM BAPTA-AM (n = 3) 
caused an average decrease in survival of 27 (95 % CI [-1, 55], p = 0.054) percentage points, 
but this was not significant. 
PCB 180 in conjunction with 10 µM U0126, 50 µM vitamin E and 3 µM MK-801 all caused 
significant increases in survival compared to 15 µM PCB 180 alone (n = 6). U0126 caused 
an average increase in survival of 8 (95% CI [1, 14], p = 0.025), vitamin E an increase of 28 
(95 % CI [18, 37], p = 0.0007) and MK-801 an increase of 19 (95 % CI [5, 33], p = 0.012) 
percentage points. 
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Figure 3-4. Survival of cerebellar granule cells after 24 hours of exposure to 15 µM PCB 180 and 
potentially neuroprotective substances in vitro. Survival values were measured with the MTT survival 
assay. Mean survival of cells and SE are presented as percentage of control (n = 3-6 in triplicate). 
Differences in survival between groups were analysed with a two-tailed, paired Student’s t-test. The 
symbols *, **, and *** indicate p < 0.05, p < 0.01 and p < 0.001 respectively. Exposure to 
neuroprotective substances alone did not cause any significant change in survival compared to 
control (n = 3-5 in triplicate). An ANOVA with Dunnet’s post hoc test was used. 
3.1.4 Neurotoxicity of low and highly chlorinated PCBs 
Cerebellar granule cells were exposed to 10, 12.5 and 15 µM solutions of PCBs with 
increasing congener number (n = 6-7). PCB 28, 52, 101, 110, 153 and 180 were tested. For 
PCBs 52, 110, 153 and 180 there was a dose dependent decrease in survival with increasing 
concentration. There was no significant decrease in survival for PCB 28 or PCB 101. An 
ANOVA with Tukey-Kramer post hoc test was used.  
None of the concentrations of PCB 28 showed a statistically significant difference in cell 
survival compared to control (Welch test, p = 0.061).  Survival in cells exposed to PCB 52 
was only significantly different from control for concentrations of 12.5 and 15 µM (p < 0.05 
and p < 0.01, respectively).  
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After exposure to 12.5 and 15 µM PCB 101, cerebellar granule cell survival was statistically 
significant from control (p < 0.01 for both). For PCBs 110, 153 and 180, concentrations of 
10, 12.5 and 15 µM all caused a statistically significant decrease in survival compared to 
control (p < 0.01 for all). Comparison between different concentrations of each PCB and 
control was done using individual ANOVA and Dunnet’s post hoc tests. Results are 
displayed in figure 3-5. 
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Figure 3-5. Survival of cerebellar granule cells in vitro after 24 hours of exposure to 10, 12.5 and 15 
µM of PCB 28, 52, 101, 110, 153 and 180. Survival was measured using the MTT assay and 
calculated as percentage of control. Survival values are presented as mean + SE (n = 6-7 in 
triplicate). The different concentrations of PCBs were compared to control with a Welch test for PCB 
28 and an ANOVA and Dunnet’s post hoc tests for PCB 52-180. Significant differences from control 
are indicated as * = p < 0.05 and ** = p < 0.01. 
In order to to determine whether there was a systematic change in mean survival with 
increasing congener number, the experimental data for each concentration of all PCBs were 
also analysed with an ANOVA with a post hoc test for a linear trend. There was a significant 
negative linear trend from PCB 28 to PCB 180 for all concentrations (p < 0.0001 for all, r
2
 = 
0.60 for 10µM, r
2 
= 0.64 for 12.5 µM and r
2
 = 0.59 for 15 µM). This indicates that the higher 
congeners induced more cell death than the lower congeners. To assess differences in 
survival between equal concentrations of different PCBs, a Tukey-Kramer post hoc test was 
used. These differences and the linear trend are illustrated in figure 3-6. 
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Figure 3-6. Survival of cerebellar granule cells in vitro after 24 hours exposure to 10, 12.5 and 15 µM 
of PCB 28, 52, 101, 110, 153 and 180, analysed using the MTT assay. Survival is calculated as 
percentage of control, and presented as mean + SE (n = 6-7 in triplicate). The diagram illustrates the 
significant negative linear trends that were found for survival with increasing congener number at all 
concentrations. Comparisons of different PCBs at the same concentrations were performed with an 
ANOVA and a Tukey-Kramer post hoc test. The letters a, b, c, d, e and f are used to represent PCB 
28, 52, 101, 110, 153 and 180, respectively. The letters above the columns indicate that survival for 
the congener represented by the column was statistically different from survival for the congeners 
indicated by the letters, when tested at the same concentration. One, two and three letters represent 
significance levels of p < 0.05, p < 0.01 and p < 0.001 respectively. I.e., “aa” above 10 µM PCB 180 
means that survival in the cells exposed to 10 µM PCB 180 was significantly different from survival in 
cells exposed to 10 µM PCB 28, with a p-value < 0.01. 
3.1.5 Neurotoxicity of penitrem A at different concentrations 
Cerebellar granule cells were exposed in triplicate to 2, 10, 12.5, 15, 20 and 40 µM penitrem 
A for 24 hours (n = 4-7). There was a dose dependent decrease in survival with increasing 
concentrations of penitrem A. Survival was found to be significantly different from control at 
all concentrations, except for 2 µM, and was reduced to 58 ± 5 % (mean ± SE) (p < 0.01) for 
10 µM, 22 ± 5 % (p < 0.001) for 12.5 µM, 13 ± 4 % (p < 0.001) for 15 µM, 6 ± 2 %  (p < 
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0.001) for 20 µM and 1.8 ± 0.2 % (p < 0.001) for 40 µM. Statistical analyses were done 
using a Welch test with a Games-Howell post hoc test. 
A best fit dose-response curve for penitrem A is presented in figure 3-7. The LC50 value 
estimated for penitrem A from this curve was 10.5 (95 % CI [9.9, 11.1]) µM. 
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Figure 3-7. Survival of cerebellar granule cells after 24 hours of exposure to 2, 10, 12.5, 15, 20 and 
40 µM penitrem A in vitro. Survival was measured with the MTT assay. The concentration values are 
log-transformed. Values are presented as mean ± SE in percent of control (n = 4-7 in triplicate). A 
Welch test with Games-Howell post hoc test was performed to detect statistical differences between 
the different concentrations and control. The symbols *, ** and *** represent p < 0.05, p < 0.01 and p 
< 0.001, respectively. LC50 for penitrem A was estimated to be 10.5 (95% CI [9.9, 11.1]) µM.  
3.1.6 Penitrem A tested with potentially neuroprotective 
substances 
Cerebellar granule cells were exposed to several potentially neuroprotective substances in 
conjunction with 12.5 µM of penitrem A for 24 hours. For graphic display, the substances 
have been divided into substances that act primarily extracellularly on receptors (figure 3-8), 
and substances acting primarily intracellularly (figure 3-9). A two-tailed, paired Student’s t-
test was used to assess differences in survival between cells exposed to penitrem A alone and 
in conjunction with neuroprotective substances. 
Cells were also incubated with inhibitors alone (n = 3-6, except 0.5 µM BAPTA-AM and 50 
µM bicuculline [n = 2], 2 µM alphaxalone and 2 µM allopregnanolone, [n = 1]). No statistics 
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could be conducted for alphaxalone and allopregnanolone, but the values are included in the 
graphs for completeness. 
When compared to incubation with penitrem A alone, no statistically significant increase in 
survival was seen for cerebellar granule cells after incubation of 12.5 µM penitrem A with 5 
µM diazepam, 150 and 300 µM pentobarbital, 300 µM phenobarbital, 2 µM 
allopregnanolone, 2 µM alphaxalone, 300 µM bicuculline, 50 µM glycine, 3 µM MK-801, 
20 µM NBQX, 10 µM U0126, 1 µM SB203580 or 0.5 µM BAPTA-AM (n = 3-7). 
GABA: Compared to penitrem A alone, there was a small but significant average increase in 
survival after exposure to 10 µM and 50 µM GABA in conjunction with 12.5 µM penitrem 
A (n = 6). For 10 µM GABA the increase was 7 (95 % CI [1,13], p < 0.024) and for 50 µM 
GABA 2.4 (95 % CI [0.5, 4.2], p = 0.0198) percentage points. 
Diazepam: 50 µM diazepam caused a statistically significant increase in survival of 14 (95 
% CI [7, 21], p < 0.01) percentage points when compared to penitrem A alone (n = 8). 
Phenobarbital: 600 µM phenobarbital caused a statistically significant increase in survival 
17 (95 % CI [3, 31], p = 0.0306) percentage points compared to penitrem A alone (n = 5).   
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Figure 3-8. Survival of cerebellar granule cells in vitro after 24 hours of exposure to 12.5 µM penitrem 
A and potentially neuroprotective agents primarily acting extracellulary. Survival was measured with 
the MTT survival assay. Mean survival of cells + SE after exposure to 12.5 µM penitrem A alone and 
in conjunction with neuroprotective agents is shown as percentage of control (n = 3-8 in triplicate). 
Differences in survival was analysed with a two-tailed, paired Student’s t-test. The symbols *, **, and 
*** indicate p < 0.05, p < 0.01 and p < 0.001, respectively. Cells were also exposed to neuroprotective 
agents alone (n = 3-6 in triplicate, except n =2 for 50 µM bicuculline). None of the neuroprotective 
agents significantly affected survival compared to control. A Welch test with a Games-Howell post 
hoc test was used. Values for 2 µM allopregnanolone and alphaxalone (n =1) are included for 
completeness, but could not be tested statistically. 
L-NAME: After incubation with 300 µM L-NAME, there was a small but significant 
increase in average survival of 3 (95 % CI [1, 6], p = 0.0267) percentage points compared to 
penitrem A alone (n = 5). 
CsA: Compared to exposure to penitrem A alone, incubation with 0.5 µM CsA caused a 
significant increase in survival of 12 (95 % CI [6, 18], p = 0.0032) percentage points (n = 7). 
Vitamin E: 50 µM vitamin E showed a significant increase in survival of 38 (95 % CI, [23, 
53], p = 0.0003) percentage points when compared to toxin alone (n = 10). 
SP600125: Compared to penitrem A alone, 10 µM SP600125 caused a significant increase 
in survival of 20 (95 % CI [11, 30], p = 0.0016) percentage points (n = 8). 
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FK-506: 1.5 µM FK-506 caused a significant increase of 11 (95% CI [5, 16], p = 0.0022) 
percentage points compared to incubation with toxin alone (n = 8). 
BAPTA-AM: Compared to penitrem A alone, incubation with 5 and 10 µM BAPTA-AM 
caused increases in survival of 20 (95 % CI [7, 33], p = 0.0086) and 21 (95 % CI [9, 33], p = 
0.0056) percentage points respectively (n = 7-8). 
To test if survival was significantly different from control for cells incubated with 
neuroprotective agents alone, a Welch test with a Games-Howell post hoc test was used. 
Only 10 µM SP600125 caused a statistically significant decrease in survival compared to 
control of 52 (95 % CI [33, 71], p < 0.001) percentage points.  
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Figure 3-9. Survival of cerebellar granule cells in vitro after 24 hours of exposure to 12.5 µM penitrem 
A and potentially neuroprotective agents primarily acting extracellulary. Survival was measured with 
the MTT survival assay. Mean survival of cells + SE after exposure to 12.5 µM penitrem A alone and 
in conjunction with neuroprotective agents is shown as percentage of control (n = 5-10 in triplicate). 
Differences in survival was analysed with a two-tailed, paired Student’s t-test. The symbols *, **, and 
*** indicate p < 0.05, p < 0.01 and p < 0.001, respectively. Cells were also exposed to neuroprotective 
agents alone (n = 3-6 in triplicate, except n =2 for 0.5 µM BAPTA-AM). To indicate where incubation 
with neuroprotective agents alone gave significantly different survival compared to control, the symbol 
# is used for p < 0.05. A Welch test with a Games-Howell post hoc test was used. 
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3.1.7 Survival after different exposure times to penitrem A and 
penitrem A with vitamin E  
Exposure of cells to 12.5 µM penitrem A and penitrem A in conjunction with 50 µM vitamin 
E was carried out for 2, 6, 8,12 and  24 hours (n = 3-4). Results are presented in figure 3-10.  
For 12.5 µM penitrem A alone, there was a time dependent decrease in survival compared to 
control with increasing exposure time. At all incubation times tested, the decrease in survival 
was significantly different from control, with an average decrease of 12 (95 % CI [5,19], p = 
0.002) percentage points for 2 hours, 15 (95 % CI [7, 22], p = 0.001) for 6 hours, 22 (95 % 
CI [10, 33], p = 0.002) for 8 hours, 53 (95 % CI [8, 98], p = 0.031) for 12 hours, and 80 (95 
% CI [61, 99], p < 0.001) percentage points at 24 hours exposure. An ANOVA with 
Dunnet’s post hoc test was used for testing data from 2, 6, 8 and 24 hours of incubation, a 
Welch test with a Games-Howell post hoc test for the data from 12 hours of incubation. 
Survival at 2, 6 and 8 hours exposure to 12.5 µM penitrem A was significantly different from 
survival at 24 hours (p = 0.015, p =0.020 and p = 0.017, respectively). A Welch test with 
Games-Howell post hoc test was used. 
After incubation of cells with 12.5 µM penitrem A in conjunction with 50 µM vitamin E, 
only survival values at 2 and 24 hours exposure were significantly different from control (p = 
0.007 and p = 0.028, respectively). An ANOVA with a Tukey-Kramer post hoc test was 
used. 
A two-tailed, paired Student’s t-test showed no significant difference in survival between 
cells incubated with and without vitamin E at 2, 6 and 8 hours. However, at 12 and 24 hours, 
incubation with vitamin E caused a significant increase in survival compared to penitrem A 
alone of 40.1 (95 % CI [0.4,79.7], p = 0.049) and 58.2 (95 % CI [29.8,86.6], p = 0.0073) 
percentage points, respectively. 
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Figure 3-10. Survival of cerebellar granule cells in vitro after 2, 6, 8, 12 and 24 hours of exposure to 
12.5 µM penitrem A alone (green graph) and penitrem A in conjunction with 50 µM vitamin E (red 
graph). Mean survival ± SE is presented as percentage of control (n = 3-4 in triplicate). Survival 
values were measured with the MTT survival assay. Comparisons between control and 12.5 µM 
penitrem A alone with and without 50 µM vitamin E, were performed using an ANOVA and Dunnet’s 
post hoc tests for 2, 6, 8 and 24 hours, and a Welch test with a Games-Howell post hoc test for 12 
hours. The symbols # and ## indicate p < 0.05 and p < 0.01 respectively. A two-tailed, paired 
Student’s t-test was used to compare 12.5 µM penitrem A with and without inhibitor for each exposure 
time. Signicant differences in survival with and without vitamin E are indicated by * and ** indicating p-
values of p < 0.05 and p < 0.01 respectively. 
3.2 ROS formation in human neutrophil granulocytes 
3.2.1 ROS formation after PCB exposure measured with the DCF 
assay 
For all the three PCBs, ROS production was found to be significantly different from control 
at 2.5, 5, 10 and 20 µM (p < 0.05 for 2.5 and 5 µM PCB 180, p < 0.01 for all others). 
However, only for PCB 52 there was a significant increase in ROS production with 
increasing concentration for the doses tested. A Welch test with a Games-Howell post hoc 
test was used for PCB 52, whereas an ANOVA with a Dunnet’s and Tuckey Kramer post hoc 
tests was used for PCB 153 and PCB 180 (n = 6-9). Average relative fluorescence values for 
the different PCBs are presented in figure 3-11. 
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Equal concentrations of the three PCBs were also compared using ANOVA and Tukey-
Kramer tests, except for 5 µM, where a Welch test with a Games-Howell post hoc test was 
used. 
2.5 µM: At 2.5 µM there was no significant difference in ROS production for the different 
PCBs.  
5 µM: There was a significant difference in ROS production between 5 µM PCB 52 and 
PCB 180. 5 µM PCB 52 induced 43 (95% CI [8, 67], p = 0.016) % more ROS than 5 µM 
PCB 180. There was no significant difference between 5 µM PCB 52 and PCB 153 or 
between 5 µM PCB 153 and PCB 180. 
10 µM: At 10 µM there was found to be a significant difference in ROS production between 
10 µM PCB 52 and PCB 153 and between 10 µM PCB 52 and PCB 180. 10 µM PCB 52 
induced 22 (95% CI [1, 59], p < 0.05) % more ROS than 10 µM PCB 153 and 41 (95% CI 
[12, 79], p < 0.01) % more than PCB 180. There was no significant difference between 10 
µM PCB 153 and 10 µM PCB 180.  
20 µM: Finally, there was a significant difference in ROS production between 20 µM PCB 
52 and 20 µM PCB 180. 20 µM PCB 52 induced 40 (95% CI [9, 82], p < 0.05) % more ROS 
than 20 µM PCB 180. There was no significant difference between 20 µM PCB 52 and 153 
or between 20 µM PCB 153 and 180. 
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Figure 3-11. ROS production in human neutrophil granulocytes after exposure to 2.5, 5, 10, and 20 
µM of PCB 52, 153 and 180. ROS formation was registered using the DCF assay. Values were 
calculated as AUC relative to DMSO control after 2 hours of readings. Mean values and SE are 
displayed (n =6-9 in triplicate). Values that were significantly different from DMSO control after an 
ANOVA with a Dunnet’s post hoc test have been marked with * for p < 0.05 or ** for p < 0.01. 
3.2.2 DCF assay measurements of ROS production after PCB 
exposure in conjunction with potential ROS inhibitors 
20 µM PCB was tested in conjunction with a range of potential inhibitors of ROS formation. 
The inhibitors were also tested alone. The results for the different PCBs with and without 
each inhibitor, as well as for the inhibitors alone, are displayed in figure 3-12, 3-13 and 3-14 
respectively. 
In the text, in certain cases, the absolute decrease in relative fluorescence values in 
percentage points after addition of an inhibitor is presented in addition to the value for the 
decrease in percent. This has been done in the cases where a decrease has been found 
statistically significant, but where the value for the decrease in relative fluorescence for the 
PCB with inhibitor is very close to the value for the decrease in relative fluorescence in 
control incubated with an inhibitor alone. In these cases, it may be debated whether ROS 
inhibition in PCB/inhibitor combinations represent a genuine inhibition of the PCB-induced 
ROS production, or could merely be attributed to a decrease in basal ROS levels caused by 
the inhibitor. This is further commented upon in the discussion section. 
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Differences between ROS production in cells exposed to 20 µM PCB with and without 
inhibitors were analysed with a two-tailed, paired Student’s t-test. Inhibitors alone were 
compared to DMSO control using an ANOVA and a Dunnet’s post hoc test. 
CsA: In comparison with PCBs alone, 0.5 µM CsA (n = 6-7) reduced ROS production 
significantly after exposure in conjunction with 20 µM PCB 180, but not in conjunction with 
PCB 52 or PCB 153. 20 µM PCB 180 with CsA caused 20 (95% CI [5, 34], p = 0.017) % 
less ROS production than PCB 180 alone. CsA alone was not significantly different from 
control (n = 5). 
1 µM U0126: When compared with PCBs alone, 1 µM U0126 (n = 7) reduced ROS 
production significantly after exposure in conjunction with 20 µM PCB 153 and PCB 180, 
but not in conjunction with PCB 52. For PCB 153, the decrease in fluorescence was 28 (95% 
[15, 41], p = 0.0021) percentage points, corresponding to a decrease in ROS production of 17 
(95 % CI [9, 25]) %. For PCB 180 fluorescence was decreased with 41 (95% CI [21, 61], p = 
0.0027) percentage points, which corresponds to a 28 (95 % CI [14, 41]) % decrease in ROS 
production. U0126 alone (n = 7) was significantly different from control, with a decrease in 
relative fluorescence of 28 (95 % CI [11, 45], p < 0.01) percentage points.                                                                                                                                                                                                                                                                    
10 µM U0126: 10 µM U0126 (n = 9) caused a significant decrease in ROS production in 
conjunction with 20 µM of all the three PCBs, when compared to PCBs alone. For PCB 52, 
the decrease was 66 (95 % CI [44, 88], p = 0.0001) %, for PCB 153 it was 70 (95 % CI [57, 
82], p < 0.0001) %, and 75 (95 % CI [63, 87], p < 0.0001) % for PCB 180. 10 µM U0126 
alone (n = 8) was significantly different from control, with a decrease in relative fluorescence 
of 79 (95 % CI [63, 96], p < 0.01) percentage points. 
Vitamin E: In comparison with PCBs alone, 50 µM vitamin E (n = 7-8) reduced ROS 
production significantly in combination with 20 µM PCB 52 and PCB180, but not with PCB 
153. The decrease in ROS production was 35 (95 % CI [13, 58], p = 0.0080) % for PCB 52, 
and 13 (95 % CI, [2, 24], p = 0.030) % for PCB 180. 50 µM vitamin E alone (n = 7) was not 
significantly different from control. 
FK-506: When compared with PCBs alone, 1.5 µM FK-506 (n = 9) reduced ROS production 
significantly in conjunction with 20 µM PCB 180, but not with PCB 52 or 153. For PCB 
180, the decrease in relative fluorescence was 30 (95 % CI, [20,40], p < 0.0001) percentage 
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points, corresponding to a decrease in ROS production of  21 (95 % CI [14, 28]) %. 1.5 µM 
FK-506 alone (n = 9) was significantly different from control, with a decrease in relative 
fluorescence of 45 (95 % CI [30, 61], p < 0.01) percentage points.  
SB203580: 1 µM SB203580 (n = 9) caused a significant decrease of ROS production in 
conjunction with 20 µM PCB 180 when compared to PCBs alone, whereas PCB 52 or 153 
did not. The decrease in relative fluorescence for PCB 180 was 22 (95 % CI [13, 32], p = 
0.0007) percentage points, which corresponds to a decrease in ROS production of 15 (95 % 
CI [9, 23]) %. 1 µM SB203580 alone (n = 9) was significantly different from control, with a 
decrease in relative fluorescence of 18 (95 % CI [2, 34], p < 0.05) percentage points. 
 
SP600125: When compared to PCBs alone, 10 µM SP600125 (n = 9) reduced ROS 
production in conjunction with 20 µM PCB 153 and PCB 180, but not with PCB 52. For 
PCB 153, the decrease in relative fluorescence was 56 (95 % CI [32, 80], p < 0.0007) 
percentage points, corresponding to 33 (95 % CI [19, 47]) % less ROS production than for 
PCB alone. For PCB 180, the decrease in fluorescence was 49 (95 % CI [39, 58], p < 0.0001) 
percentage points, corresponding to a 34 (95 % CI [27, 41]) % decreased ROS production. 
10 µM SP600125 alone (n = 9) was significantly different from control, with a decrease in 
relative fluorescence of 61 (95 % CI [45, 76], p < 0.01) percentage points  
 
BAPTA-AM: In comparison with PCBs alone, 5 µM BAPTA-AM (n = 8) in conjunction 
with 20 µM of all the three PCBs caused significantly less ROS production. The decrease in 
ROS production was 32 (95 % CI, [22, 42], p = 0.0001) % for PCB 52, 33 (95 % CI [19, 47], 
p = 0.0007) % for PCB 153, and 32 (95 % CI [25, 39], p < 0.0001) % for PCB 180. 5 µM 
BAPTA-AM alone (n = 8) was significantly different from control, with a decrease in 
relative fluorescence of 24 (95 % CI [8, 40], p < 0.01) percentage points.  
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Figure 3-12. ROS production in human neutrophil granulocytes after exposure to 20 µM PCB 52 and 
different potential inhibitors of ROS. ROS production was measured using the DCF assay. Values 
were calculated as AUC relative to DMSO control after 2 hours of readings. Mean values and SE are 
given for 20 µM PCB 52 alone and in conjunction with an inhibitor (n = 7-9 in triplicate). Differences in 
ROS production were analysed with a two-tailed, paired Student’s t-test. The symbols *, **, and *** 
indicate p < 0.05, p < 0.01 and p < 0.001, respectively. Cells were also exposed to inhibitors alone (n 
= 7-9 in triplicate). Inhibitors alone were compared to control with an ANOVA and a Dunnet’s post hoc 
test. Significant differences from control are marked with # for p < 0.05 and ## for p < 0.01.  
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Figure 3-13. ROS production in human neutrophil granulocytes after exposure to 20 µM PCB 153 and 
different potential inhibitors of ROS. ROS production was measured using the DCF assay. Values 
were calculated as AUC relative to DMSO control after 2 hours of readings. Mean values and SE are 
given for 20 µM PCB 153 alone and in conjunction with an inhibitor (n = 7-9 in triplicate). Differences 
in ROS production were analysed with a two-tailed, paired Student’s t-test. The symbols *, **, and *** 
indicate p < 0.05, p < 0.01 and p < 0.001, respectively. Cells were also exposed to inhibitors alone (n 
= 7-9 in triplicate). Inhibitors alone were compared to control with an ANOVA and a Dunnet’s post hoc 
test. Significant differences from control are marked with # for p < 0.05 and ## for p < 0.01.  
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Figure 3-14. ROS production in human neutrophil granulocytes after exposure to 20 µM PCB 180 and 
different potential inhibitors of ROS. ROS production was measured using the DCF assay. Values 
were calculated as AUC relative to DMSO control after 2 hours of readings. Mean values and SE are 
given for 20 µM PCB 180 alone and in conjunction with an inhibitor (n = 6-9 in triplicate). Differences 
in ROS production were analysed with a two-tailed, paired Student’s t-test. The symbols *, **, and *** 
indicate p < 0.05, p < 0.01 and p < 0.001, respectively. Cells were also exposed to inhibitors alone (n 
= 7-9 in triplicate). Inhibitors alone were compared to control with an ANOVA and a Dunnet’s post hoc 
test. Significant differences from control are marked with # for p < 0.05 and ## for p < 0.01.  
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3.2.3 Luminol-chemiluminescence assay measurements of ROS 
production after exposure to PCBs 
ROS production was also measured using the luminol-chemiluminescence assay after 
exposure of human granulocytes to 2.5, 5, 10 and 20 µM PCB 52, PCB 153 and PCB 180 (n 
= 5-8). Average relative chemiluminescence values for the different PCBs are presented in 
figure 3-15. 
There was a dose dependent increase in ROS production with increasing concentration for all 
of the three PCBs. All the concentrations tested were significantly different from control for 
PCB 52 (p = 0.019 for 2.5 µM and 5 µM, p = 0.013 for 10 µM and p = 0.001 for 20 µM) and 
PCB 153 (p = 0.006 for 2.5 µM, p = 0.023 for 5 µM, p = 0.016 for 10 µM, p = 0.014 for 20 
µM), whereas for PCB 180, this was the case for 10 and 20 µM (p = 0.033 and p = 0.004, 
respectively). An individual Welch test with a Games-Howell post hoc test was used for each 
PCB. 
Equal concentrations of the three PCBs were also compared using ANOVA and Tukey-
Kramer tests, except for 10 µM, where a Welch test with a Games-Howell post hoc test was 
used. 
2.5 µM and 5 µM: At 2.5 and 5 µM there was no significant difference in relative 
luminescence for the different PCBs. 
10 µM: At 10 µM there was a significant difference in ROS production when PCB 52 was 
compared to PCB 153 and PCB 180. PCB 52 caused 116 (95 % CI [3,232], p < 0.049) % 
more ROS production than 153, and 203 (95% CI [41,366], p < 0.020) % more than PCB 
180. There was no significant difference in relative luminescence between 10 µM PCB 153 
and 10 µM PCB 180.  
20 µM: 20 µM PCB 52 also caused significantly more ROS production than PCB 153 and 
PCB 180. It caused 111 (95 % CI [37,186], p < 0.01) % more ROS production than PCB 
153, and 138 (95 % CI [51,225], p < 0.01) % more than PCB 180.  
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Figure 3-15. ROS production in human neutrophil granulocytes after exposure to 2.5, 5, 10, and 20 
µM of PCB 52, 153 and 180.ROS production was measured using the luminol chemiluminescence 
assay. Values were calculated as AUC relative to DMSO control after 1 hour of readings. Mean 
values and SE are displayed (n = 5-8 in triplicate).Values that were significantly different from DMSO 
control after a Welch test with a Games-Howell post hoc test have been marked with * for p < 0.05 or 
** for p < 0.01.  
3.2.4 Luminol assay measurements of ROS production after 
exposure to PCBs in conjunction with ROS inhibitors  
 
Also the luminol-chemiluminescence assay was used to measure ROS production for 20 µM 
PCB tested in conjunction with a range of potential inhibitors of ROS formation. The 
inhibitors were also tested alone. The results for the different PCBs with and without each 
inhibitor, as well as for the inhibitors alone, are displayed in figure 3-16, 3-17 and 3-18 
respectively. 
Differences between cells exposed to 20 µM PCB with and without inhibitors was analyzed 
by a two-tailed, paired Student’s t-test. Inhibitors alone were compared to DMSO control by 
a Welch test with a Games-Howell post hoc test. 
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CsA: When compared to PCBs alone, 0.5 µM CsA (n = 10-11) reduced ROS production 
significantly in conjunction with 20 µM of all the three PCBs. The decrease in relative 
luminescence was 20 (95 % CI [11, 29], p = 0.0006) % for PCB 52, 23 (95 % CI [8, 38], p = 
0.0066) % for PCB 153, and 25 (95 % CI [3, 47], p = 0.0296) % for PCB 180. CsA alone (n 
= 10) was significantly different from control, with a decrease in ROS production of 57 (95 
% CI [24, 90], p < 0.001) %.  
1 µM U0126: Compared to PCBs alone, addition of 1 µM U0126 (n = 7-8) reduced ROS 
production significantly in conjunction with 20 µM PCB 52, but not in conjunction with 20 
µM PCB 153 or 20 µM PCB 180. The decrease in relative luminescence was 27 (95 % CI [6, 
48] p = 0.0212) % for PCB 52. 1 µM U0126 alone (n = 8) was not significantly different 
from control. 
10 µM U0126: 10 µM U0126 (n = 9) reduced ROS production significantly when in 
conjunction with 20 µM of all the three PCBs, compared to PCBs alone. The decrease in 
ROS production was 73 (95 % CI [49, 96], p < 0.0001) % for PCB 52, 69 (95 % CI [44,95], 
p = 0.0003) % for PCB 153, and 75 (95 % CI [54,97] p < 0.0001) % for PCB 180. 10 µM 
U0126 alone (n = 9) was significantly different from control, with a decrease in ROS 
production of 69 (95 % CI [42, 97], p < 0.001) %. 
Vitamin E: Compared to PCBs alone, 50 µM vitamin E (n = 9-11) reduced ROS production 
significantly in conjunction with 20 µM of all the three PCBs. The decrease was 65 (95 % CI 
[42, 87], p = 0.0002) % for PCB 52, whereas it was 34 (95 % CI [18,48], p = 0.0006) % for 
PCB 153 and 38 (95 % CI [15,61], p = 0.0049) % for PCB 180. Vitamin E alone (n = 10) 
was not significantly different from control. 
FK-506: There was a significant decrease in ROS production for all the three PCBs when 
incubated with 1.5 µM FK-506 (n = 9-10). The decrease was 42 (95 % CI [20,64], p = 
0.0023) % for PCB 52, 34 (95 % CI [16,51], p = 0.0017) % for PCB 153, and 39 (95 % CI 
[20,58], p = 0.0015) % for PCB 180. FK-506 alone (n = 9), was significantly different from 
control, with a decrease in ROS production of 68 (95 % CI [37,98], p < 0.001) %. 
SB203580: For all three PCBs, incubation of 20 µM PCB with 1 µM SB203580 (n = 9-10) 
reduced ROS production significantly compared to exposure to 20 µM PCB alone. The 
decrease was 41 (95 % CI [17, 65], p = 0.0044) % for PCB 52, 28 (95 % CI [7, 49], p = 
 72 
0.0154) % for PCB 153 and 29 (95 % CI [7,50], p = 0.0138) % for PCB 180. SB203580 
alone (n = 9) was significantly different from control, with a decrease in ROS production of 
35 (95 % CI [10, 61], p = 0.004) %.  
SP600125: 1 µM SP600125 in conjunction with 20 µM of all the three PCBs (n = 9-10) 
showed significantly lower ROS production than PCBs alone. The decrease was 44 (95 % CI 
[20, 68], p = 0.0028) % for PCB 52, 54 (95 % CI [24, 84], p = 0.0026) % for PCB 153 and 
62 (95 % CI [32,92], p = 0.0015) % for PCB 180. SP600125 alone (n = 9) was significantly 
different from control, with a decrease in ROS production of 84 (95 % CI [50,118], p < 
0,001) %. 
BAPTA-AM: Finally, compared to PCBs alone, 5 µM BAPTA-AM (n = 9-10) reduced ROS 
production significantly when incubated in conjunction with 20 µM of all the three PCBs. 
The decrease in ROS production was 86 (95 % CI [46,126], p = 0.0012) % for PCB 52, 76 
(95 % CI [47,105], p = 0.0002) % for PCB 153, and 68 (95 % CI [43, 93], p = 0.0003) % for 
PCB 180. BAPTA-AM alone (n = 9) was significantly different from control, showing a 
decrease in ROS production of 62 (95 % CI [22,102], p = 0.002) %. 
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Figure 3-16. ROS production in human neutrophil granulocytes after exposure to 20 µM PCB 52 and 
different potential inhibitors of ROS. ROS production was measured using the luminol 
chemiluminescence assay. Values were calculated as AUC relative to DMSO control (set to 100 %) 
after 1 hour of readings. Mean values and SE are displayed (n = 7-10 in triplicate). Differences in 
ROS production were analysed with a two-tailed, paired Student’s t-test. The symbols *, **, and *** 
indicate significance levels of p < 0.05, p < 0.01 and p < 0.001, respectively. Cells were also exposed 
to inhibitors alone (n = 8-10 in triplicate). Inhibitors alone were compared to control with a Welch test 
and a Games-Howell post hoc test. Statistically significant differences between inhibitors alone and 
control are marked with # for p < 0.05, ## for p < 0.01 and ### for p <0.001.  
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Figure 3-17. ROS production in human neutrophil granulocytes after exposure to 20 µM PCB 153 and 
different potential inhibitors of ROS. ROS production was measured using the luminol 
chemiluminescence assay. Values were calculated as AUC relative to DMSO control after 1 hour of 
readings. Mean values and SE are displayed (n = 8-11 in triplicate). Differences in ROS production 
were analysed with a two-tailed, paired Student’s t-test. The symbols *, **, and *** indicate 
significance levels of p < 0.05, p < 0.01 and p < 0.001, respectively. Cells were also exposed to 
inhibitors alone (n = 8-10 in triplicate). Inhibitors alone were compared to control with a Welch test and 
a Games-Howell post hoc test. Statistically significant differences between inhibitors alone and 
control are marked with # for p < 0.05, ## for p < 0.01 and ### for p <0.001. 
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Figure 3-18. ROS production in human neutrophil granulocytes after exposure to 20 µM PCB 180 and 
different potential inhibitors of ROS. ROS production was measured using the luminol 
chemiluminescence assay. Values were calculated as AUC relative to DMSO control (set to 100 %) 
after 1 hour of readings. Mean values and SE are displayed (n = 7-11 in triplicate). Differences in 
ROS production were analysed with a two-tailed, paired Student’s t-test. The symbols *, **, and *** 
indicate significance levels of p < 0.05, p < 0.01 and p < 0.001, respectively. Cells were also exposed 
to inhibitors alone (n = 8-10 in triplicate). Inhibitors alone were compared to control with a Welch test 
and a Games-Howell post hoc test. Statistically significant differences between inhibitors alone and 
control are marked with # for p < 0.05, ## for p < 0.01 and ### for p <0.001. 
3.2.5 Preliminary studies of penitrem A-induced ROS production 
Preliminary studies of ROS induction in human neutrophil granulocytes were conducted for 
10 µM penitrem A together with PCB in fluorescence and chemiluminescence experiments. 
Results were compared using 20 µM 153 PCB as a positive control, as this PCB has 
previously been studied and shown to induce ROS formation (Reistad and Mariussen, 2005). 
Comparisons between groups were done using a Welch test and a Games-Howell post hoc 
test. Results are presented in figures 3-19 and 3-20.  
With the DCF assay (n = 9) both 20 µM PCB 153 and 10 µM penitrem A reached values for 
ROS formation that were significantly different from the DMSO control. The relative 
fluorescence values after exposure to 20 µM PCB 153 was 166 ± 14 % (mean ± SE) (p = 
0.003), compared to 314 ± 24 % (mean ± SE) (p < 0.001) for 10 µM penitrem A. 
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10 µM penitrem A induced significantly more ROS than 20 µM PCB 153. Penitrem A 
caused 89 (95 % CI [42,137], p = 0.001) % more ROS formation than the PCB. Because 
penitrem A induced significantly more ROS than the PCB, which was known to induce ROS 
production, it was decided that no positive control would have to be included in the further 
pentitrem A ROS experiment. 
With the luminol chemiluminescence assay (n = 11) exposure to 10 µM penitrem A did not 
cause ROS levels that were significantly different from DMSO control. The relative 
chemiluminescence after exposure to 20 µM PCB 153 was 669 ± 116 % (mean ± SE) (p = 
0.002), whilst 10 µM penitrem A caused a chemiluminescence of 128 ± 16 % (mean ± SE) 
(p = 0.268). The PCB 153 was interpreted as a positive control, indicating that penitrem A 
did not induce significant amounts of ROS that were detectable with the luminol assay. 
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Figure 3-19. Relative fluorescence as a measure of ROS production in human neutrophil 
granulocytes after exposure to 10 µM penitrem A, with 20 µM PCB 153 as a positive control. Mean 
and SE for 9 experiments are shown. Values significantly different from control have been indicated 
with * representing a p-value of < 0.05, assessed with a Welch test and a Games-Howell post hoc 
test.  
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Figure 3-20. Relative chemiluminescence as a measure of ROS production in human neutrophil 
granulocytes after exposure to 10 µM penitrem A, with 20 µM PCB 153 as a positive control. Mean 
and SE for 11 experiments are shown. Values significantly different from control have been indicated 
with * representing a p-value of < 0.05, assessed with a Welch test and a Games-Howell post hoc 
test.  
3.2.6 Measurements of penitrem A-induced ROS production using 
the DCF assay 
Also ROS production after exposure of human granulocytes to 1 nM, 10 nM, 250 nM, 750 
nM, 2 µM, 10 µM and 12.5 µM penitrem A was measured using the DCF assay (n = 5-9). 
Average relative fluorescence values for penitrem A are presented in figure 3-21. For 
penitrem A, there was a dose dependent increase in ROS production with increasing 
concentration. Concentrations of 250 nM and above were significantly different from control 
when assessed with a Welch test and a Games-Howell post hoc test (p = 0.017 for 250 nM, p 
= 0.029 for 750 nM, p = 0.005 for 2 µM, p = 0.014 for 10 µM and p = 0.035 for 12.5 µM). 
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Figure 3-21. Relative fluorescence as a measure of ROS production in human neutrophil 
granulocytes, after exposure to 1 nM, 10 nM, 250 nM, 750 nM, 2 µM, 10 µM and 12.5 µM penitrem A. 
Values were calculated as AUC relative to DMSO control after 2 hours of readings. Mean values and 
SE are displayed (n = 5 – 9). Values significantly different from DMSO control are indicated with * or 
**, representing p < 0.05 and p < 0.01, respectively. A Welch test and a Games-Howell post hoc test 
were used. 
3.2.7 Potential inhibitors and their effect on ROS production after 
penitrem A exposure, assessed with the DCF-fluorescence 
assay 
10 µM penitrem A was analysed in the DCF assay in conjunction with several 
pharmacological inhibitors of intracellular pathways potentially leading to ROS formation. 
The inhibitors were also tested alone. Relative fluorescence values as a measure of 
granulocyte ROS production are displayed in figure 3-22. Differences in ROS production 
between cells exposed to 10 µM penitrem A alone and in conjunction with an inhibitor were 
analyzed using a two-tailed, paired Student’s t-test. Inhibitors alone were compared to 
DMSO control with an ANOVA and a Dunnet’s post hoc test.  
As discussed in chapter 3.2.2, also here absolute fluorescence values are given when found 
necessary, as these are relevant for the discussion of whether ROS inhibition in penitrem 
A/inhibitor combinations represent a genuine inhibition of the penitrem A-induced ROS 
production, or could merely be attributed to decreased basal ROS levels caused by the 
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inhibitor. 
 
All the inhibitors tested caused a statistically significant decrease in ROS production with the 
exception of 1 µM U0126. 
CsA: For 0.5 µM CsA (n = 8), there was a decrease in ROS production of 41 (95 % CI [21, 
60], p = 0.0017) %. CsA alone (n = 7), was significantly different from the DMSO control, 
with a decrease in relative fluorescence of 24 (95 % CI [1, 48], p < 0.05) percentage points. 
10 µM U0126: For 10 µM U0126 (n = 7), there was a decrease in ROS production of 51 (95 
% CI [24, 78], p = 0.0037) %. 10 µM U01216 alone (n = 6) was significantly different from 
the DMSO control, with a decrease in relative fluorescence of 72 (95 % CI [48, 96], p < 
0.01) percentage points. 
Vitamin E: For 50 µM vitamin E (n = 7), there was a decrease in ROS production of 61 (95 
% CI [28, 94], p = 0.0041) %. Vitamin E alone (n = 6) was not significantly different from 
the DMSO control. 
FK-506: For 1.5 µM FK-506 (n = 6), there was a decrease in ROS production of 41 (95 % 
CI [25, 57], p =0.0011) %. FK-506 alone (n = 6) was significantly different from the DMSO 
control, with a decrease in relative fluorescence of 32 (95 % CI [8, 57], p < 0.01) percentage 
points. 
SB203580: For 1 µM SB203580 (n = 6), there was a decrease in ROS production of 28 (95% 
CI [6, 51], p = 0.0238) %. SB203580 alone (n = 6) was not significantly different from the 
DMSO control. 
SP600125: For 1 µM SP600125 (n = 6), there was a decrease in ROS production of 52 (95% 
CI [36, 68], p = 0.0004) %. SP600125 alone (n = 6) was significantly different from the 
DMSO control, with a decrease in relative fluorescence of 62 (95 % CI [37, 86], p < 0.01) 
percentage points.  
BAPTA-AM: For 5 µM BAPTA-AM (n = 6), there was a decrease in ROS production of 32 
(95 % CI [8, 56] p = 0.0185) %. BAPTA-AM alone (n = 6) was significantly different from 
the DMSO control, with a decrease in relative fluorescence of 26 (95 % CI [1, 50], p < 0.05) 
percentage points. 
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L-NAME: Finally, for 300 µM L-NAME (n = 6), there was an average decrease in relative 
fluorescence of 25 (95 % CI [1, 48], p = 0.0423) percentage points, corresponding to a 
decrease of 8 (95 % CI [0.3, 15]) %. L-NAME alone (n = 6) was not significantly different 
from the DMSO control, though it had a non significant decrease in relative fluorescence of 
23 (95 % CI [-2, 47], p > 0.05) percentage points.  
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Figure 3-22.  ROS production in human neutrophil granulocytes after exposure to 10 µM penitrem A 
and different potential inhibitors of ROS. ROS production was measured using the DCF assay. 
Values were calculated as AUC relative to DMSO control after 2 hours of readings. Mean values and 
SE are given for 10 µM penitrem A alone and in conjunction with an inhibitor (n = 6-8 in triplicate). 
Differences in ROS production were analysed with a two-tailed, paired Student’s t-test. The symbols 
*, **, and *** indicate significance levels of p < 0.05, p < 0.01 and p < 0.001, respectively. Cells were 
also exposed to inhibitors alone (n = 6-7 in triplicate). Inhibitors alone were compared to control with 
an ANOVA and a Dunnet’s post hoc test. Significant differences from control are marked with # for p 
< 0.05 and ## for p < 0.01. 
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3.3 LDH assay 
 
The LDH assay was carried out to assess that no significant damage to the cell membrane of 
the human granulocytes had occurred during incubation with the toxic substances. No 
statistically significantly elevated levels of LDH were detected for 20 µM PCB 52, 153 or 
180 or for 10 µM penitrem A, indicating that the cell membranes had not been disrupted 
during the incubation period. An ANOVA with a Dunnets’s post hoc test was used for 
statistcal comparisons.  
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4. Discussion 
4.1 Main results 
In this study higher chlorinated PCBs induced more cell death in cerebellar granule cell 
cultures than lower chlorinated congeners. Cytoprotective effects were found for the 
substances vitamin E, MK-801 and U0126. The mycotoxin penitrem A caused more cell 
death in the same cell type with increasing concentration and exposure time. The substances 
GABA, phenobarbital, diazepam, vitamin E, BAPTA-AM, SP600125, FK-506 and CsA 
reduced cell death after penitrem A exposure. 
The lower chlorinated PCBs induced more ROS production in human neutrophil 
granulocytes than the higher chlorinated congeners. The substances U0126, BAPTA-AM, 
vitamin E, SP600125, SB203580, FK-506 and CsA significantly reduced ROS production 
after PCB exposure. There was a dose dependent increase in ROS production in the 
granulocytes with exposure to increasing concentrations of penitrem A. The same substances 
inhibited ROS production after penitrem A exposure as after PCB exposure. 
4.2 Cerebellar granule cells 
4.2.1 Cerebellar granule cells as a model 
Cerebellar granule cells were used to study the neurotoxicity of different PCBs and the 
mycotoxin penitrem A. Results from studies in primary cell cultures may potentially vary a 
lot depending on the state of the cells. It was observed that several factors could influence the 
quality of the cells, such as the batch of calf serum and bovine serum albumin used. The time 
from decapitation of rat pups until the cerebellum was removed seemed to be important, as 
well as the total time used for the isolation of cells.This has also been described by 
Oberdoerster (2001).  
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The cell quality seemed to affect the PCB results by shifting the dose response curve 
horizontally. However, this seemed to affect the PCBs equally, and the relative differences 
between PCBs should not be influenced. Variation would also be observed between results 
from different laboratories. Results from toxicity studies obtained in vitro may also vary if 
different assays are used to estimate cell viability. A method such as the trypan blue assay, 
which detects a disrupted cell membrane, will not necessarily give the same result as the 
MTT assay, which detects viable mitochondria. Finally, results obtained from in vitro 
cultures may not correspond to result from in vivo studies. Cells may be influenced by other 
factors in cultures than in the body, and many factors present in the body are impossible to 
mimic in vitro.  In any case, the values obtained in vitro can only represent a “best estimate”.  
Furthermore, when the toxic substances were tested in conjunction with potentially 
neuroprotective drugs, it seemed important to do this at a concentration where the toxic 
substances alone did not reduce survival too much. If tested with a concentration that 
resulted in a very low level of survival, the neuroprotective substances seemed unable to 
influence cell death. Because of this, it was chosen to test both 15 and 20 µM solutions of 
PCB 180 with the neuroprotective substances, whereas PCB 52 was tested with the 
substances at 20 µM. 15 µM PCB 180 and 20 µM PCB 52 gave approximately the same 
level of survival.  
For penitrem A, cell quality seemed to affect results to a lesser degree than for the PCBs.  
Overall, cerebellar granule cells were found to be good models for neurotoxicity studies after 
exposure to both PCB and penitrem A.   
4.2.2  Toxicity studies of low and highly chlorinated PCBs 
In order to assess if there were differences between the toxicity of low- and highly 
chlorinated ortho-substituted PCBs, cerebellar granule cells were exposed to the 
tetrachlorobiphenyl PCB 52 and the heptachlorobiphenyl PCB 180. Both PCBs showed a 
dose dependent decrease in survival with increasing concentration. There was a statistically 
significant difference between the LC50 values at 24 hours for the two PCBs, estimated to 
14.3 and 9.5 µM for PCB 52 and PCB 180, respectively, indicating a higher toxicity of the 
highly chlorinated PCB. 
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Using the trypan blue exclusion assay, Mariussen et al. (2002) estimated the LC50 value for 
another highly chlorinated ortho-substituted PCB, the hexachlorobiphenyl PCB 153, to 8 µM 
after 24 hours of exposure. This is quite close to the LC50 value estimated for PCB 180 
during these studies, despite the fact that the results were obtained in different laboratories 
with different techniques.  
Cerebellar granule cells were also exposed to a selection of ortho-substituted PCBs with 
increasing degree of chlorination. The figures 3-5 and 3-6 show that toxicity increased with 
increasing concentration and chlorination. 
PCB 28, the lowest chlorinated PCB, was not significantly different from control at any 
concentration. PCB 28 is a mono-ortho-chlorinated trichlorobiphenyl that does not bind to 
the Ah receptor (Robertson and Hansen, 2001). Exposure of neonatal mice in vivo to PCB 28 
has been associated with neurotoxic effects in the adult (Eriksson and Fredriksson, 1996). In 
vitro studies of acutely isolated cerebellar granule cells have shown neurotoxicity of PCB 28 
(Tan et al., 2004). One can not rule out that it would have exerted significant neurotoxic 
effects had higher doses been tested.  
At the lowest concentration tested, PCB 101 did not cause a significant reduction in survival 
when compared to control, but did so for the higher concentrations. For the higher 
chlorinated PCBs, the pentachlorobiphenyl PCB 110, the hexachlorobiphenyl PCB 153 and 
the heptachlorobiphenyl PCB 180, caused a significant reduction in survival even at 10 µM, 
indicating a higher toxicity for these congeners than the trichlorobiphenyl PCB 28, the 
tetrachlorobiphenyl PCB 52 and the pentachlorobiphenyl PCB 101.  
Higher toxicity of PCBs with higher chlorination was also reported by Tan et al. (2004), in a 
study of acutely isolated cerebellar granule cells, involving di-, tri- and tetrachlorobiphenyls, 
including PCB 28 and PCB 52. Mariussen et al. (2001) found that higher chlorinated ortho-
substituted PCBs partially inhibited GABA and glutamate uptake in brain synaptosomes 
even at very low concentrations, which may lead to excitotoxicity (Mariussen et al., 2001).  
It has been reported that PCBs with high and low degrees of chlorination may act via 
different mechanisms. In an in vitro study by Fernandes et al. (2010), which included all the 
above mentioned PCBs except PCB 110, the lower chlorinated congeners PCB 28 and PCB 
52 were shown to act as agonists at the GABAA receptor. These effects are not seen for the 
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higher chlorinated PCBs. Furthermore, in an in vivo study by Boix et al. (2010), offspring 
from female rats showed different symptoms after exposure of the mother to low- and highly 
chlorinated PCBs during pregnancy and lactation. The lower chlorinated PCB, represented 
by PCB 52, showed a negative effect on motor coordination. The higher chlorinated PCBs, 
represented by PCB 138 and PCB 180, affected learning ability. 
Boix et al. (2010) proposed that developmental exposure to PCB 52 increases GABA in the 
cerebellum, thus impairing motor coordination, whereas exposure to PCB 138 and 180 could 
cause a decrease in the amount of NMDA receptors in the cerebellum. GABA is involved 
both in learning, memory and motor activity (Fernandes et al., 2010). Activation of NMDA 
receptors causes an increase in intracellular calcium, which activates NOS with a subsequent 
increase in NO. This again activates guanylate cyclase and increases cyclic GMP (cGMP). 
Decreased activation of this pathway due to a decreased number of NMDA receptors could 
cause impairment of learning abilities (Boix et al., 2010). 
The highly chlorinated PCB 153, which was found to be one of the most neurotoxic PCBs in 
this study, has often been the most prominent congener detected in breast milk, human tissue 
and blood (Guo et al., 1997; Kowalski et al., 2010). Epidemiological studies indicate that 
PCB exposure is associated with learning disabilities and hyperactivity disorders (Mariussen 
and Fonnum, 2006). Thus, it is a cause of concern that infants may be exposed to this 
neurotoxic congener via placental transfer and ingestion of breast milk from mothers with 
high levels of PCBs in their tissues. 
To summarise, the presented results strongly indicate that higher chlorinated ortho-
substituted PCBs are more toxic than the lower chlorinated PCBs to cerebellar granule cells 
in vitro. However, lower chlorinated PCBs may also exert a toxic effect. As postulated by 
Fernandes et al. (2010) and Boix et al. (2010), different mechanism may be involved in the 
toxicity of higher chlorinated and lower chlorinated PCBs. 
4.2.3 Potential mechanisms of PCB neurotoxicity 
Several substances were studied in conjunction with PCB 52 and 180 to assess whether any 
of these had a cytoprotective effect. Vitamin E, an antioxidant, increased cerebellar granule 
cell survival after exposure to both PCB 52 and PCB 180, indicating an involvement of ROS 
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production.Vitamin E has been included in previous studies of PCB toxicity in cerebellar 
granule cells. Mariussen et al. (2002) found that it protected against cell death, and also 
reduced ROS formation, indicating a connection between free radical formation and cell 
death. As earlier mentioned, vitamin E is thought to scavenge lipid peroxyl radicals (Wang 
and Quinn, 2000), singlet oxygen (
1
O2) (Kaiser et al., 1990), ONOO
-
 (Hogg et al., 1994) and 
O2
•-
 (Ha and Csallany, 1992). Unpublished results from our laboratory show that ROS 
production was induced in cerebellar granule cells after exposure to several ortho-chlorinated 
PCBs, with an increase in ROS production related to decreasing chlorination (Dreiem A., 
personal communication, 2010). At 20 µM, the increase in survival after incubation with 
vitamin E was 42 percentage points in conjunction with PCB 52, as compared to 24 
percentage points for PCB 180. The fact that the increase in survival with vitamin E was 
greater for the lower chlorinated PCB may reflect that it induces higher levels of ROS 
production than the higher chlorinated. 
 
Figure 4-1. Pathways that may be activated by PCBs leading to ROS formation in cerebellar granule 
cells. Potential inhibitors of the pathways are shown in italics. Adapted from Fonnum et al. (2006). 
MK-801 increased survival with by 17 percentage points for PCB 52 at 20µM, and 19 
percentage points at 15 µM PCB 180. This may indicate that the NMDA receptor is involved 
in the mechanism of toxicity for both PCBs. MK-801 binds inside the calcium channel of the 
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NMDA receptor, preventing influx of calcium ions into the cell. PCB is thought to bind to 
the NMDA receptors and increase the number of receptors on the cell surface, triggering an 
influx of calcium, which may lead to activation of several cascades leading to apoptosis or 
necrosis (Ndountse and Chan, 2009). Involvement of the NMDA receptor and protective 
effects of MK-801 after PCB exposure have previously been by reported by Mariussen et al. 
(2002) in cerebellar granule cells, and by Ndountse and Chan (2009) in neuroblastoma cells.  
Ndountse and Chan (2009) also found a protective effect of memantine after PCB exposure. 
Memantine is also an NMDA receptor blocker, but a less potent one than MK-801 (Weller et 
al., 1993). In the current study no significant effect was found for 3 µM memantine. 
Ndountse and Chan, however, used a higher dose of 10 µM. In future studies, it may be of 
interest to use higher doses of memantine also in cerebellar granule cells. 
BAPTA-AM, on the other hand, seemed to potentiate the toxic effect of 20 µM PCB 52, 
causing a decrease in survival of 24 percentage points and a non-significant decrease of 27 
percentage points for 15 µM PCB 180 (p = 0.054). As the focus in this study main was on 
identifying substances that had protective properties, only 3 experiments were carried out 
with BAPTA-AM at 15 µM PCB 180. Given the p-value and the magnitude of the decrease, 
it is possible to hypothesise that BAPTA-AM in conjunction with PCB 180 may also have 
exerted a negative effect on survival. This, however, cannot be confirmed without further 
studies. 
The reduced survival observed using BAPTA-AM during PCB studies in cerebellar granule 
cells was in contrast to the increased survival observed in human neuroblastoma cells by 
Ndountse and Chan (2009). Their findings were done after exposure of neuroblastoma cells 
to BAPTA-AM in conjunction with PCB 126, PCB 99 and Araclor 1254. BAPTA-AM is an 
intracellular calcium chelator (Ndountse and Chan, 2009). The maintenance of intracellular 
calcium homeostasis is necessary for a normally functioning cell (Mariussen and Fonnum, 
2006). Thus, decreasing the intracellular levels of free calcium may possibly interfere with 
the cell control mechanisms. Changes in intracellular calcium levels after PCB exposure may 
occur by different mechanisms in different types of cell preparations prior to cell death 
(Fonnum and Mariussen, 2009). This may possibly contribute to the diverging results from 
the two cell types. However, further research would be needed to make conclusions about 
this effect of PCBs and BAPTA-AM. 
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For cerebellar granule cells exposed to 15 µM PCB 180, the MEK 1/2 and MEK 5 inhibitor 
U0126 also increased survival by 8 percentage points. The biological relevance of this could 
be questioned, but Dreiem et al. (2009) found that survival in cerebellar granule cells after 
exposure to hydroxylated PCBs was increased after addition of U0126. This was, however, 
to a much greater extent than observed here. CsA caused a trivial increase in survival of 2 
percentage points. The biological relevance of this result, however, is probably negligible. 
U0126 and CsA did not cause any significant change in survival when incubated with PCB 
52. L-NAME did not increase survival in any of the PCB experiments. 
To summarise, the results indicate that both PCB 52 and PCB 180 seem to act via the 
NMDA receptor, and ROS production may be involved in their toxicity, as indicated by the 
protective effect of vitamin E. Disturbances of cellular calcium homeostasis seem to 
potentiate the toxicity of PCB 52. 
4.2.4 Penitrem A neurotoxicity 
To assess the neurotoxic potential of penitrem A in cerebellar granule cells, the cells were 
incubated with different concentrations of the toxin for 24 hours. A dose dependent decrease 
in survival after exposure was observed. The LC50 value for penitrem A was estimated to 
10.5 µM. There have been no published results on penitrem A toxicity in cerebellar granule 
cells, but the presence of necrotic foci in the granular cell layer of the cerebellum were 
reported by Cavanagh et al. (1998), 6 hours after intraperitoneal injections of the toxin in 
vivo. In the same study, substantial degeneration of Purkinje cells, another type of neurone 
found in the cerebellum, was found. 
The results show that penitrem A is toxic to cerebellar granule cells in vitro. 
4.2.5 Possible mechanisms of penitrem A neurotoxicity 
To elicit factors involved in penitrem A-induced death in cerebellar granular cells, the toxin 
was studied in conjunction with different substances in order to identify if any of these would 
increase survival after exposure to the toxin. There are currently two main theories 
concerning the cause of the neurological symptoms after exposure to fungal diterpenes such 
as penitrem A. One involves the blockage of high conductance calcium activated potassium 
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channels (BK channels) in the presynaptic neuronal membrane. This may lead to an 
increased duration of action potentials by the prevention of cell repolarisation, causing an 
increased release of neurotransmittors from the presynaptic membrane. 
The other theory is that the neurological symptoms are caused by an imbalance between 
excitatory and inhibitory influences in the brain (Moldes-Anaya, A., 2010). Moldes-Anaya et 
al. (2010) found that penitrem A inhibited reuptake of GABA and glutamate in rat cerebellar 
synaptosomes. They postulated that this may cause an accumulation of GABA and glutamate 
in the synaptic cleft, prolonging the action of the neurotransmittors on their receptors. 
Moldes-Anaya et al. (2010) also found that penitrem A did not bind to the NMDA or AMPA 
receptors, which opposes an earlier proposed hypothesis that penitrem A induces 
excitotoxicity via direct action on these receptors. It was also hypothesised that penitrem A 
binds to a site on the GABAA receptor that partly overlaps with the binding site for the 
GABA antagonist bicuculline. Bicuculline is a convulsant that blocks synaptic inhibition 
through GABA receptors by antagonising the action of GABA at the GABA binding site 
(Johnston, 1996; Rang et al., 2007). 
In this study, several different drugs acting on the GABAA, NMDA and AMPA receptors 
were tested. In concurrence with the findings of Moldes-Anaya et al. (2010), there was no 
significant increase in cerebellar granule cell survival after exposure to penitrem A when 
incubated in conjunction with the NMDA recepetor antagonist MK-801 or the AMPA 
receptor antagonist NBQX. There was no significant increase in cell survival when penitrem 
A exposed cells were incubated in conjunction with glycine.  
However, there was a 14 percentage point increase in survival after incubation with a 600 
µM solution of the barbiturate phenobarbital, and a 17 percentage point increase after 
incubation with a 50 µM solution of the benzodiazepine diazepam. This indicates that the 
GABAA receptor may be involved in mechanisms leading to cell death after penitrem A 
exposure. Alleviation of convulsions in dogs intoxicated with penitrem A after ingestion of 
contaminated food has been observed after treatment with pentobarbital and phenobarbital, 
both alone or in conjunction with the anticonvulsant diazepam (Moldes-Anaya, A., 2010). 
There was also minor significant increases in survival of 7 and 2 percentage points after 
exposure to 10 and 50 µM GABA, respectively. The biological relevance of such small 
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increases, however, is questionable. There was no significant change in survival after 
exposure to penitrem A in conjunction with the GABA antagonist bicuculline, the 
neurosteroids allopregnanolone or alphaxolone, or the barbiturate pentobarbital. 
Vitamin E significantly increased survival by 38 percentage points when cells were 
incubated with this in conjunction with penitrem A. This suggests a potential role of ROS 
production in the toxicity of penitrem A in nerve cells, as vitamin E is a fast acting 
antioxidant scavenging both lipid peroxyl radicals and intracellular free radicals. 
Furthermore, concentrations of 5 and 10 µM of the intracellular calcium chelator BAPTA-
AM caused increases of 20 and 21 percentage points, respectively, after incubation in 
conjunction with penitrem A. This suggests that an increase in intracellular free calcium is 
induced during penitrem A exposure. However, this should be confirmed with further 
studies. 
The MAPKs belong to a family of protein kinases that transmit signals to the nucleus. As 
earlier mentioned, five subfamilies have been identified, the ERK 1/2, ERK 3/4, JNK, p38 
and ERK 5 (Schaeffer and Weber, 1999; Chen et al., 2005). The MAPKs are believed to be 
important molecules in cell death induced by extracellular stimuli (Schaeffer and Weber, 
1999). 
SP600125 is a selective inhibitor of the JNK pathway (Bennett et al., 2001). FK-506 and 
CsA are both inhibitors of the JNK and p38 MAPK pathways (Matsuda et al., 2000), 
whereas SB203580 is a selective inhibitor of the p38 pathway (Cuenda et al., 1995). U0126 
is an inhibitor of the ERK 1/2 and ERK 5 pathways (Favata et al., 1998; Kamakura et al., 
1999). Cerebellar granule cell survival after penitrem A exposure was increased by 20 
percentage points when incubated with SP600125, and 10 and 12 percentage points with FK-
506 and CsA respectively. No increase in survival was seen for SB203580 or U0126. 
Increased survival after exposure to SP600125, FK-506 and CsA, but not after exposure to 
SB203580, suggests an involvement of the JNK pathway in penitrem A induced neuronal 
cell death, but not of the p38 pathway. Incubation of cells with SP600125 alone, decreased 
survival by 52 %, something which could indicate that the JNK pathway is important in the 
regulation of survival in cerebellar granule cells. 
 91 
CsA may also inhibit the mitochondrial transition pore (Bernardi et al., 1994). Opening of 
this pore by increased intracellular calcium may cause the production of O2
•-
 (Fonnum et al., 
2006). Calcium is also capable of activating the NOS pathway, causing the formation of NO
•
 
(Fonnum et al., 2006). L-NAME, a NOS inhibitor (Moncada and Higgs, 1991; Anderson and 
Meyer, 1996), also caused a trivial increase in survival of 3 percentage points.The biological 
relevance of this is debatable.  
To summarise, penitrem A induced cell death in cerebellar granule cells seems to involve the 
GABAA receptor. An increase in intracellular free calcium may also be involved. Increased 
intracellular calcium may again be linked to the formation of ROS. Increased survival after 
incubation with vitamin E may indicate involvement of ROS formation in penitrem 
neurotoxicity. Increases in calcium may open mitochondrial transition pores, which may 
result in production of O2
•-
. CsA blocks these pores (Fonnum et al., 2006). An increase in 
survival after CsA treatment indicates that opening of mitochondrial transition pores may be 
a possible step in ROS production. Finally, the pro-apoptotic JNK pathway may possibly be 
involved in penitrem A neurotoxicity. Activation of this pathway has been linked to 
increases in calcium in studies involving macrophages and other toxicants (Kim and Sharma, 
2004). In future studies, it may be interesting to assess whether this may also be the case in 
cerbellar granule cells after penitrem A exposure. 
4.2.6 Neurotoxicity of penitrem A at different times of exposure 
Cerebellar granule cells were incubated with penitrem A for 2, 6, 8, 12 and 24 hours to 
assess effects of exposure time on its neurotoxic potential. For 12.5 µM penitrem A alone, 
there was a time dependent decrease in survival with increasing exposure time. When cells 
were exposed to penitrem A in conjunction with vitamin E such a decrease in survival was 
not observed. Even at 12 and 24 hours, when survival in cells exposed to penitrem A was as 
low as 47 and 20 percent, respectively, incubation with vitamin E increased survival 
significantly to 87 and 78 percent. 
In summary, this indicates that the toxic effect of penitrem A in cerebellar granule cells 
increases with exposure time, and that vitamin E gives a substantial protection even after 24 
hours of exposure. 
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4.3 Human neutrophil granulocytes  
4.3.1 Human neutrophil granulocytes as a model 
Human granulocytes were used as a model to study ROS production after exposure to PCBs 
and penitrem A. During the preliminary experiments, it was observed that DMSO inhibited 
basal ROS production in control cells quite substantially, especially when measured by the 
DCF method. As all the substances that were to be tested for effects on ROS production, as 
well as the toxic substances, were dissolved in DMSO, it became apparent that DMSO 
controls with the same volume of DMSO had to be included. This allowed for fluorescence 
and luminescence values to be calculated as percentage of these controls, correcting for the 
inhibitory effect of DMSO on ROS production. 
For the PCBs both the DCF method and the luminol chemiluminescence method gave useful 
results, as has previously been observed by Myhre et al. (2003) and Myhre et al. (2009). In 
the mentioned studies similar levels of ROS production were detected by the two methods. In 
the current study, however, ROS levels were much higher when measured with the luminol 
chemiluminescence method than with the DCF method.  
For penitrem A, no significant ROS production was detected when assessed with the luminol 
chemiluminescence method, possibly indicating that HOCl is not the main ROS induced by 
the toxin. The DCF method, however, was found useful, detecting significant levels of ROS 
compared to DMSO control.  
That no significant release of LDH was detected after incubation of cells with the toxic 
substances, indicated that the cell membranes had not been disrupted during the incubation 
period. This suggests that measured fluorescence/luminescence would be due to ROS created 
intracellularly in viable cells.    
4.3.2  ROS production in human neutrophil granulocytes after PCB 
exposure 
In order to assess if there was a difference between low and highly chlorinated PCBs in their 
potential to induce ROS production, cells were exposed to different doses of the 
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tetrachlorinated PCB 52, the hexachlorinated PCB 153, and the heptachlorinated PCB 180. 
ROS production was quantified using the DCF and luminol assays. 
With both assays, all the tested doses of the three PCBs caused statistically significant 
increases in ROS compared to control, except 2.5 and 5 µM PCB 180 with the luminal assay. 
All PCBs caused a dose dependent increase in ROS production when assessed with the 
luminol assay. However, when measured using the DCF assay, there was a dose dependent 
increase in ROS production with increasing concentration only for PCB 52.  
For both assays, the lower chlorinated PCB 52 caused significantly higher levels of ROS 
production than the higher chlorinated PCBs 153 and 180 at 10 and 20 µM. The exception 
was PCB 153 at 20 µM, which was not significantly different from PCB 52 when measured 
with the DCF assay. However, differences between ROS induction after exposure to higher 
and lower chlorinated PCBs were much larger when measured using the luminol assay. 
These results indicate that the lower chlorinated PCBs such as PCB 52 may induce a greater 
production of ROS in human neutrophil granulocytes than the highly chlorinated PCBs such 
as PCB 180. The reactive oxygen species detected by these methods are ONOO
-
, 
•
OH, H2O2 
and HOCl (Myhre et al., 2003). In concurrence, Voie et al. (2000) reported that induction of 
ROS was dependent on size of the congener. Congeners of larger size, corresponding to 
PCBs with high congener numbers and many chlorine substitutions, were reported to be less 
potent. The most active were reported to be the moderately sized congeners with several 
ortho-substitutions.  
Interestingly, as earlier mentioned, unpublished results from our laboratory also showed the 
same tendency in cerebellar granule cells. Lower chlorinated PCBs seemed to induce more 
ROS than the higher chlorinated ones when assessed with the DCF assay (Dreiem A., 
personal communication, 2010).  
That the lower chlorinated PCBs may induce a greater production of ROS in human 
neutrophil granulocytes, could perhaps implicate that the lower chlorinated PCBs have a 
greater capability of inadvertent activation of neutrophils and effects on the immune system. 
Voie et al. (1998) postulated that defects in neturophil function after PCB exposure may 
render the host more susceptible to pathogen invasion, or initiate inappropriate activation of 
inflammatory responses, causing tissue damage. 
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4.3.3 Assessment of pathways involved in ROS production after 
PCB exposure 
The NADPH oxidase of the human neutrophil granulocytes may be activated by several 
signalling pathways, that may be interdependent (Myhre et al., 2009). To try to identify some 
of the pathways involved in the induction of ROS production after exposure to PCBs, several 
pharmacological inhibitors of intracellular pathways were used in conjunction with the toxic 
substances. ROS was measured both using the DCF and the luminol chemiluminescence 
assays. 
When cells were exposed to 10 µM U0126, a reduction of approximately 70 % in ROS 
production was observed with both assays for all the three PCBs. U0126 inhibits MEK 1/2 
and MEK 5 (Favata et al., 1998; Kamakura et al., 1999). MEK 1/2 is found upstream of 
ERK 1/2 MAPK and MEK 5 upstream of ERK5. Both ERK 1/2 and ERK 5 phosphorylate 
and activate NADPH oxidase (Aam, 2007). Thus, the results indicate that these pathways 
may be involved in the production of ROS for all the three PCBs. 
When measured with the luminol assay, 1 µM U0126 in conjunction with the PCBs caused a 
significant reduction in PCB 52 induced ROS production of 27 %. Measured using the DCF 
assay, 1 µM U0126 reduced ROS production significantly for the higher chlorinated 
congeners PCB 180 and PCB 153 when compared to PCB alone. However, the reduction in 
relative fluorescence after PCB 153 exposure in conjunction with 1 µM U0126 was not 
larger than the decrease in relative fluorescence observed in cells exposed to 1 µM U0126 
alone (see figure 3-13). Due to this, one can not rule out that the decrease was only due to a 
inhibition of basal ROS production (see section 2.4.2) in the cell and not due to a decrease in 
the PCB induced ROS. Ultimately, this means that although the decrease in ROS production 
was statistically significant, it is not possible to conclude from the DCF data that there is a 
real effect of the inhibitor. 
BAPTA-AM reduced ROS production in PCB exposed granulocytes for all PCBs with 
approximately 30 % and 68-86 % when measured with the DCF and luminol assays, 
respectively. As BAPTA-AM is an intracellular calcium chelator (Ndountse and Chan, 
2009), this may indicate that increased intracellular calcium levels are involved in the 
induction of ROS production. 
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Incubation with vitamin E caused significant reduction in ROS production for all PCBs 
measured with both assays, with the exception of 20 µM PCB 153 assessed with the DCF 
assay. Decreases were higher for the lower chlorinated PCB 52 than for the others. The 
observed reduction in ROS levels might be expected as an effect of vitamin E, as it is a 
known fast-acting antioxidant and ROS scavenger. 
Several of the tested inhibitors act on the JNK and p38 MAPK pathways. SP600125 is a 
selective inhibitor of the JNK pathway (Bennett et al., 2001), SB203580 a selective inhibitor 
of the p38 pathway (Cuenda et al., 1995), and FK-506 and CsA may act on both pathways 
(Matsuda et al., 2000). Measured with the luminol assay SP600125 decreased ROS 
production with 44-62 %, whereas SB203580 caused a reduction of 28-41 % for the three 
different PCBs. FK-506 decreased ROS production with 34-42 % and CsA 20-25 % for the 
three congeners. For PCB 180, CsA showed a similar decrease when measured with the DCF 
assay. All these results suggest the involvement of both the p38 MAPK and the JNK 
pathways in ROS production for all the different PCBs.  
The problem of distinguishing between inhibition of basal ROS production and PCB-induced 
ROS production, as described for 1 µM U0126, was also observed when ROS was measured 
using the DCF assay for some other inhibitors. These included the p38 and JNK pathway 
inhibitor FK-506, the selective p38 inhibitor SB203580 and the selective JNK inhibitor 
SP600125. The DCF data for these inhibitors did not allow for conclusions to be drawn 
about their effects, although they caused statistically significant decreases in ROS 
production. The data from the luminol data proved more useful in this respect.  
 
Overall, the results suggest that similar pathways seem to be involved in inducing ROS 
production in human neutrophil granulocytes after exposure to the three different PCBs. Due 
to an observed reduction in ROS production caused by the different inhibitors, the four 
MAPK families ERK 1/2, JNK, p38 and ERK 5 are likely to be involved in induction of 
ROS production. An increase in intracellular calcium also seems important for the ROS 
production.  
Previous findings have shown that single ortho-substituted PCBs and PCB mixtures such as 
Aroclor 1242 induce ROS formation in human neutrophil granulocytes (Voie et al., 1998; 
Voie et al., 2000; Myhre et al., 2003; Myhre et al., 2009). MAPK, PKC and Ca
2+
 are thought 
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to be important factors in the activation of NADPH oxidase (Myhre et al., 2009). Voie et al. 
(1998) hypothesised that PCB activated ROS production in human granulocytes was 
dependent on the phosphatidylinositol-3 kinase, the Ca
2+
 dependent phospholipase D (PLD) 
and/or phospholipase C (PLC) and protein kinase C (PKC) activation before activation of the 
NADPH oxidase (Voie et al., 1998). PLD may also be involved in activation of the p38 
pathway (Myhre et al., 2009). In addition, Myhre et al. (2009) found that the ERK 1/2 
kinases, p38 MAPK, JNK and/or calcineurin pathways were involved in the activation of the 
respiratory burst after exposure to Aroclor 1242.  
A presentation of the possible signalling pathways involved in the PCB induced activation of 
NADPH during ROS production, and inhibitors of the different pathways, is presented in 
figure 4-2. 
 97 
 
Figure 4-2. Important intracellular pathways involved in ROS formation in human neutrophil 
granulocytes after PCB exposure. The MAP kinase pathways ERK 1/2, ERK 5, p38 and JNK are 
shown. The ERK 1/2 pathway is activated through tyrosine kinases (TRK) by extracellular signal 
substances. P38 and JNK pathways are primarily activated in situations of cellular stress. The 
phospholipases C and D (PLC/PLD) may also activivate protein kinase C via intermediate signal 
substances. IP3 produced by phospholipases causes release of Ca
2+
 from the endoplasmic reticulum 
(ER). PLD may be involved in activatation of the p38 pathway. Adapted from Myhre et al. (2009). 
4.3.4 ROS production in human neutrophil granulocytes after 
penitrem A exposure 
To assess the ability of penitrem A to induce ROS production, human neutrophil 
granulocytes were exposed to different concentrations of penitrem A. A dose dependent 
increase in ROS production was detected with increasing concentrations, and concentrations 
above 250 nM induced statistically significant levels of ROS production as compared to 
control. Thus the results indicate that ROS production may be an important mechanism of 
action in penitrem induced cell damage. An investigation on the ability of penitrem A to 
induce ROS production in nerve cells, would be an interesting target for further studies.  
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4.3.5 Mechanisms of ROS-induction after penitrem A exposure 
To identify possible pathways involved in the penitrem A-induced ROS production, the 
effects of inhibitors of different intracellular pathways were assessed. Penitrem A-induced 
ROS production was significantly inhibited by the MEK 1/2 and MEK 5 inhibitor U0126, 
the p38 and JNK pathway inhibitors FK-506 and CsA, the selective p38 inhibitor SB203580 
the selective JNK inhibitor SP600125,  the intracellular calcium chelator BAPTA-AM and 
vitamin E. The NOS inhibitor L-NAME had only a minor effect. 
The results thus suggest that the MAPK families ERK1/2, ERK 5, p38 and JNK may all be 
involved in the induction of ROS production in human neutrophil granulocytes after 
exposure to penitrem A. Increased levels of intracellular Ca
2+
 may also contribute to the 
increase in ROS formation. 
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5. Conclusions and future perspectives  
One of the aims of this thesis was to investigate whether there are differences in 
neurotoxicity between low and highly chlorinated ortho-substituted PCBs, and attempt to 
identify factors involved in their neurotoxicity. Based on the results presented, there is a 
strong indication that the higher chlorinated ortho-substituted PCBs are more toxic to 
cerebellar granule cells than are the lower chlorinated. However, the latter are also 
neurotoxic. As discussed different mechanisms may be involved in the toxicity of lower and 
higher chlorinated PCBs, giving rise to distinct effects after in vivo exposure.  
In the current study, ROS production and NMDA receptor involvement in neurotoxicity in 
cerebellar granule cells were indicated by the protective actions of the antioxidant vitamin E, 
and the NMDA receptor channel blocker MK-801 for both PCB 52 and 180. As mentioned, 
it was also observed in unpublished studies from our laboratory that a higher level of ROS 
production was induced by lower chlorinated PCBs than the higher chlorinated ones. This 
could possibly suggest that ROS production is more important in neurotoxicity induced by 
lower chlorinated PCBs than for the higher chlorinated PCBs.  
An interesting aim for future studies could be experiments with specific inhibitors of ROS 
production pathways in cerebellar granule cells, using the same PCBs. Also, some of the 
inbibitors used in the human granulocyte experiment, such as FK-506, SP600125 and 
SB203580 could be tested in studies of PCB-induved ROS production in cerebellar granule 
cells. This might elicit if any of the same pathways that are in involved in ROS production in 
the granulocytes also are involved in cell death in the cerebellar granule cells. Further 
replicates with the inhibitor BAPTA-AM could be performed in order to obtain statistically 
significant results also for PCB 180. However, the usefulness of performing further PCB 
toxicity studies in cerebellar granule cells must be weighted against the fact that the 
experiments require sacrification of a considerable number of animals. 
Results from human neutrophil granulocyte experiments showed that the lower chlorinated 
PCBs were more potent at inducing ROS production than the highly chlorinated PCBs at 
higher concentrations. Studies with inhibitors of different intracellular pathways indicated 
that the MEK 1/2 and MEK 5 pathways, the p38 pathway and the JNK pathway, as well as 
 100 
an increase in intracellular calcium, may all be involved in the induction of ROS production 
in human neutrophil granulocytes after PCB exposure.  
The results from neurotoxicity studies of penitrem A indicate that it is toxic to cerebellar 
granule cells in vitro. Studies with potentially neuroprotective substances indicated that the 
GABAA receptor could be involved in the induction of cell death. An increase in intracellular 
calcium and the activation of the JNK pathway may also be involved. Increased survival after 
co-incubation of penitrem A with vitamin E indicated that ROS production could potentially 
be involved in the mechanism of toxicity. 
The ability of penitrem A to induce ROS production was further confirmed by the human 
granulocyte experiments. The MEK 1/2, the MEK 5, the p38 and the JNK pathways as well 
as an increase in intracellular calcium could be involved in induction of ROS in human 
neutrophil granulocytes after penitrem A exposure. 
In future studies, it would be interesting to use the DCF method to assess ROS production in 
cerebellar granule cells after penitrem A exposure, as this was the method found to yield 
interesting results in the human neutrophil granulocytes. Furthermore, it would be of interest 
to study intracellular levels of free calcium after penitrem A exposure, and also to assess if 
there is a link between intracellular calcium levels and ROS production, or between calcium 
levels and activation of the JNK pathway.  
The exact mechanism of penitrem A neurotoxicity has not been identified. As menitoned, the 
studies of the mycotoxin showed that it was capable of inducing ROS production in human 
neutrophil granulocytes. ROS production in cerebellar granule cells was also suggested by 
the protective action of vitamin E. Based on the findings it could be hypothesised that ROS 
production could be an important cause of cell death after penitrem A exposure, in addition 
to the two earlier proposed mechanisms of an inactivation of BK channels or an imbalance 
between excitatory and inhibitory influences in the brain (Moldes-Anaya, A., 2010). Further 
studies on penitrem A-induced ROS production in nerve cells should be conducted. 
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7.  Appendix 
7.1 Solutions for cerebellar granule cell experiments 
7.1.1 Solutions for the cultivation of cerebellar granule cells 
Solutions and medium for the cultivation of cerebellar granule cells were prepared on the day 
preceding the cultivation. Their contents are listed below. All solutions that were not sterile, 
were filtered through 0,22 µm filters (Sarsted, Nümbrecht,Germany).: 
Krebs-Ringer (10x):     NaCl      35.35 g 
        KCl      1.80 g 
        KH2PO4     0.83 g 
        Glucose     12.85 g 
        NaHCO3     10.70 g 
        Phenol red     50 mg 
        Distilled water    500 ml 
 
Solution 1:       BSA      0.3 g 
        Krebs-Ringer (10x)   10 ml 
        MgSO4 (3,28g/100ml dH2O)  0.8 ml 
        Millique water    100 ml 
 
Solution 2:       Trypsin     5 mg  
        Solution 1     20 ml 
 
Solution 3:       DNase     1.25 mg 
        Trypsin inhibitor (SBT1)  5.2 mg 
        Solution 1     10 ml 
 
Solution 4:       Solution 3     3,2 ml 
        Solution 1     20 ml 
 
Poly-L-lysine (10x): 12.5 ml batches frozen Poly-L-lysine    5 mg 
        Autoclaved Millique water  50 ml 
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ARA-C:  3 ml batches frozen   Cytosine arabinofuranoside  1 mg  
  
        Basal medium Eagle   10 ml 
 
Cell culture medium:     Basal medium Eagle   440 ml 
        KCl      825 mg 
        Glucose     500 mg 
        Glutamax (200 mM)   5 ml  
       P/S (100IU/ml)/(100µg/ml)  5 ml 
       Foetal bovine serum   50 ml 
 
7.1.2 Solutions for exposure of cells to toxic substances and MTT 
cell survival assay 
Medium for exposure of cells:    Basal medium Eagle   490 ml 
        KCl      825 mg 
        Glucose     500 mg 
        Glutamax (200 mM)   5 ml 
P/S (100IU)/100µg   5 ml 
 
1 x PBS buffer for MTT solution, pH 7.4 NaCl      8.00 g 
        KCl      0.20 g 
        Na2HPO4     1.44 g 
        KH2PO4     0.24 g 
        Distilled water    1 L 
 
7.2 Solutions for human neutrophil granulocyte 
experiments 
7.2.1 Solutions for human neutrophil granulocyte experiments 
The following solutions were prepared for several experiments at the time and kept either 
refrigerated or frozen: 
0.9 % NaCl - refrigerated    NaCl      9.0 g 
                   Distilled water    1 L 
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6 % dextran in 0.9 % NaCl - refrigerated  Dextran     6.0 g  
        0.9 % NaCl    100 ml 
 
0.83 % NH4Cl  - refrigerated   NH4Cl     4.15 g 
        Distilled water    500 ml 
 
0.5 M glucose - frozen in batches of 500 µl Glucose     4.505 g
        Distilled water    50 ml 
 
5 mM DCFH-DA – frozen    DCFH-DA     1 mg 
        Methanol     410 µl 
 
0.1 M luminol - frozen in batches of 30 µl  Luminol     8.86 mg
        DMSO     500 µl 
  
1x Hanks’ Balanced Salt Solution (HBSS)  
buffer with 4.17 mM NaHCO3 - refrigerated HBSS (x10)               50 ml 
        Distilled water    450 ml 
        NaHCO3     175 mg
     
The above buffer was supplemented with  
hepes and glucose at the day of cell isolation 
giving 1x HBSS with 4.17 mM NaHCO3 ,  
20 mM HEPES and 5 mM glucose   1x HBSS with NaHCO3  49 ml 
        1 M HEPES    1 ml 
        0.5 M glucose    0.5 ml  
 
 
